<SEC-DOCUMENT>0001564590-18-014929.txt : 20180601
<SEC-HEADER>0001564590-18-014929.hdr.sgml : 20180601
<ACCEPTANCE-DATETIME>20180601163520
ACCESSION NUMBER:		0001564590-18-014929
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20180531
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Termination of a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20180601
DATE AS OF CHANGE:		20180601

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CYTORI THERAPEUTICS, INC.
		CENTRAL INDEX KEY:			0001095981
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				330827593
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-34375
		FILM NUMBER:		18875554

	BUSINESS ADDRESS:	
		STREET 1:		3020 CALLAN ROAD
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		8584580900

	MAIL ADDRESS:	
		STREET 1:		3020 CALLAN ROAD
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MACROPORE INC
		DATE OF NAME CHANGE:	20010320
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>cytx-8k_20180601.htm
<DESCRIPTION>8-K
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
cytx-8k_20180601.htm
</title>
</head>
<!-- NG Converter v5.0.18092.123 -->
<body>

<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">UNITED STATES</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">SECURITIES AND EXCHANGE COMMISSION</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Washington, D.C. 20549</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:16pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Form 8-K</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Current Report&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date of Report<font style="font-weight:bold;">&#160;</font>(Date of earliest event reported):<font style="font-weight:bold;">&#160; May 31, 2018</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:20pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">CYTORI THERAPEUTICS, INC.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(Exact name of registrant as specified in its charter)</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr style="height:1pt;">
<td valign="top"  style="width:33.34%; border-bottom:solid 0.75pt #FFFFFF;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Delaware</p></td>
<td valign="top"  style="width:33.34%; border-bottom:solid 0.75pt #FFFFFF;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">001-34375</p></td>
<td valign="top"  style="width:33.32%; border-bottom:solid 0.75pt #FFFFFF;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">33-0827593</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top"  style="width:33.34%; border-bottom:solid 0.75pt #FFFFFF;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(State or Other Jurisdiction</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">of Incorporation)</p></td>
<td valign="top"  style="width:33.34%; border-bottom:solid 0.75pt #FFFFFF;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Commission</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">File Number)</p></td>
<td valign="top"  style="width:33.32%; border-bottom:solid 0.75pt #FFFFFF;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(I.R.S. Employer</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Identification Number)</p></td>
</tr>
</table></div>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">3020 Callan Road, San Diego, California 92121</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(Address of principal executive offices, with zip code)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">(858) 458-0900</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(Registrant's telephone number, including area code)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">n/a</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(Former name or former address, if changed since last report)</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark whether the registrant<font style="color:#070707;"> is an emerging growth company as defined in as defined in Rule 405 of the Securities</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-right:7.22%;text-indent:-0.04%;color:#070707;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Act of 1933 (&#167; 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167; 240.12b-2 of this chapter). </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;color:#070707;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.<font style="color:#000000;font-size:11pt;"> &#9633;</font> </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#070707;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Emerging<font style="letter-spacing:0.2pt;"> </font>growth<font style="letter-spacing:0.15pt;"> </font>company<font style="letter-spacing:0.45pt;"> </font><font style="color:#000000;font-size:11pt;">&#9633;</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.67%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<font style="font-style:italic;">see</font> General Instruction A.2. below):</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="hangingindent"></a><a name="hangingindent"></a>&#160;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:540pt;;">
<tr>
<td style="width:15.15pt;"></td>
<td style="width:15.15pt;"></td>
<td style="width:509.7pt;"></td>
</tr>
<tr style="height:15.45pt;">
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#9633;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="&#116;&#97;&#98;&#50;"></a>&#160;&#160;&#160;&#160;Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td>
</tr>
</table></div>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:540pt;;">
<tr>
<td style="width:15.15pt;"></td>
<td style="width:15.15pt;"></td>
<td style="width:509.7pt;"></td>
</tr>
<tr style="height:15.45pt;">
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#9633;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p></td>
</tr>
</table></div>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:539.9pt;;">
<tr>
<td style="width:15.15pt;"></td>
<td style="width:15.15pt;"></td>
<td style="width:509.6pt;"></td>
</tr>
<tr style="height:15.45pt;">
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#9633;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p></td>
</tr>
</table></div>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:539.9pt;;">
<tr>
<td style="width:15.15pt;"></td>
<td style="width:15.15pt;"></td>
<td style="width:509.6pt;"></td>
</tr>
<tr style="height:15.45pt;">
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#9633;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:36pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;"><a name="pgbrk"></a>&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:859.55pt;;"></table></div>
<hr style="page-break-after:always;width:100%;">
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:859.55pt;;">
<tr>
<td style="width:400.5pt;"></td>
<td style="width:459.05pt;"></td>
</tr>
<tr>
<td style="width:400.5pt;"></td>
<td style="width:459.05pt;"></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="hdr"></a><a name="_AEIOULastRenderedPageBreakAEIOU2"></a><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Item 1.01.&nbsp;&nbsp;Entry into a Material Definitive Agreement.</font></p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On June 1, 2018, Cytori Therapeutics, Inc. (the &#8220;Company&#8221; or &#8220;Cytori&#8221;) entered into a Sales Agreement (the &#8220;Sales Agreement&#8221;) with B. Riley FBR, Inc. (&#8220;B. Riley FBR&#8221;) to sell shares of its Common Stock, par value $0.001 (the &#8220;Common Stock&#8221;), having an aggregate offering price of up to $6,500,000 (the &#8220;Shares&#8221;) from time to time, through an &#8220;at the market&#8221; equity offering program (the &#8220;ATM Offering&#8221;) under which B. Riley FBR will act as sales agent. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The offer and sale of the Shares will be made pursuant to the Company&#8217;s effective &#8220;shelf&#8221; registration statement on Form S-3 (File No. 333-217988), the base prospectus contained therein, dated April 10, 2018, and a prospectus supplement related to the ATM Offering, dated June 1, 2018. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This Current Report on Form 8-K shall not constitute an offer to sell or the solicitation of any offer to buy the Shares, nor shall there be any offer, solicitation or sale of the Shares in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Subject to the terms and conditions of the Sales Agreement, B. Riley FBR will use its commercially reasonable efforts to sell the Shares, based upon the Company&#8217;s instructions, consistent with its normal trading and sales practices and applicable state and federal laws, rules and regulations and rules of the Nasdaq Stock Market LLC. The Company will set the parameters for sales of the Shares, including the number of Shares to be sold, the time period during which sales are requested to be made, any limitation on the number of Shares that may be sold in one trading day, and any minimum price below which sales may not be made. Under the Sales Agreement, B. Riley FBR may sell the Shares by any method permitted by law deemed to be an &#8220;at the market offering,&#8221; as defined in Rule 415 of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). The Company has no obligation to sell any of the Shares and may at any time suspend offers and sales under the Sales Agreement. The Company and B. Riley FBR each have the right, in their sole discretion, to terminate the Sales Agreement at any time upon prior written notice as provided in the Sales Agreement.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company will pay to B. Riley FBR a commission, or allow a discount, in an amount equal to 3.0% of the gross sales price per share of Common Stock sold through it as sales agent under the Sales Agreement. In addition, the Company has agreed to reimburse B. Riley FBR for certain expenses it incurs in the performance of its obligations under the Sales Agreement up to a maximum of $30,000. The Company has also agreed pursuant to the Sales Agreement to indemnify and provide contribution to B. Riley FBR against certain liabilities, including liabilities under the Securities Act. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The foregoing description of the terms of the Sales Agreement is subject to, and qualified in its entirety by, the Sales Agreement, a copy of which is filed as Exhibit 10.1 hereto and incorporated herein by reference. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The legal opinion of Latham &amp; Watkins LLP, counsel to the Company, relating to the Shares is filed as Exhibit 5.1 hereto. </p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:276.3%;">
<tr>
<td style="width:85.58%;"></td>
<td style="width:190.73%;"></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:12pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="P266527175"></a><a name="T0"></a><a name="T0"></a>Item 1.02.<font style="color:#000000;">&nbsp;&nbsp;Termination</font><font style="color:#000000;font-weight:normal;"> </font>of a Material Definitive Agreement.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:12pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="S116383257"></a><a name="T1"></a><a name="T2"></a><a name="T3"></a><a name="T4"></a><a name="T5"></a>On May 31, 2018, the Company provided written notice to <font style="color:#000000;">Cowen and Company, LLC (&#8220;Cowen&#8221;) </font><a name="T1"></a>of&#160;<a name="T2"></a>termination of the parties&#8217; Sales <a name="T3"></a>Agreement dated May 12, 2014 (the &#8220;<a name="T4"></a>Prior Sales Agreement&#8221;). Under the&#160;Prior Sales Agreement, the Company could sell from time to time, at its option, up to an aggregate of $40.0 million of shares of its common stock through Cowen, as sales agent. The termi<a name="T5"></a>nation will become effective ten days after the Company&#8217;s written notice to Cowen, or June 10, 2018.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.91%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="T6"></a><a name="T7"></a><a name="T6"></a>The foregoing description of the&#160;<a name="T7"></a>Prior Sales Agreement is qualified in its entirety by reference to the complete text of the Prior Sales Agreement, a copy of which was filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K, filed with the Securities and Exchange Commission on May 12, 2014.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">***</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU3"></a><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cautionary Statement Regarding Forward-Looking Statements</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This Current Report on Form 8-K includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but not are not limited to, statements regarding the ability to sell shares and raise additional funds pursuant to the Sales Agreement.&nbsp;&nbsp;Such statements involve risks and uncertainties that could cause Cytori&#8217;s actual results and financial position to differ materially. These risks and uncertainties include uncertainties associated with market conditions and the satisfaction of pre-sale conditions under the Sales Agreement, and other risks described under the heading &#8220;Risk Factors&#8221; in Cytori&#8217;s Securities and Exchange Commission Filings on Form 10-K and Form 10-Q. Cytori assumes no responsibility to update or revise any forward-looking statements to reflect events, trends or circumstances after the date hereof.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Item 9.01.&nbsp;&nbsp;Financial Statements and Exhibits.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:5.6%;font-size:10pt;font-family:inherit;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d)&#160;&#160;&#160;&#160;Exhibits </p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:98.62%;">
<tr>
<td colspan="3" valign="middle"  style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle"  style="width:13%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="middle"  style="width:8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="middle"  style="width:79%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom"  style="padding-left:1.1pt;padding-Right:1.1pt;padding-Top:1.1pt;padding-Bottom:1.1pt;width:auto;">
<p style="text-align:center;margin-bottom:6pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:inherit;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Exhibit No.</font></p></td>
<td valign="bottom"  style="padding-left:1.1pt;padding-Right:1.1pt;padding-Top:1.1pt;padding-Bottom:1.1pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:inherit;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  style="padding-left:1.1pt;padding-Right:1.1pt;padding-Top:1.1pt;padding-Bottom:1.1pt;width:auto;">
<p style="text-align:center;margin-bottom:6pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:inherit;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Description</font></p></td>
</tr>
<tr>
<td valign="top"  style="padding-left:1.1pt;padding-Right:1.1pt;padding-Top:1.1pt;padding-Bottom:1.1pt;width:auto;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.1</p></td>
<td valign="top"  style="padding-left:1.1pt;padding-Right:1.1pt;padding-Top:1.1pt;padding-Bottom:1.1pt;width:auto;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom"  style="padding-left:1.1pt;padding-Right:1.1pt;padding-Top:1.1pt;padding-Bottom:1.1pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="cytx-ex51_6.htm"><font style="text-decoration:underline;">Opinion of Latham &amp; Watkins LLP</font></a></p></td>
</tr>
<tr>
<td valign="top"  style="padding-left:1.1pt;padding-Right:1.1pt;padding-Top:1.1pt;padding-Bottom:1.1pt;width:auto;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.1</p></td>
<td valign="top"  style="padding-left:1.1pt;padding-Right:1.1pt;padding-Top:1.1pt;padding-Bottom:1.1pt;width:auto;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom"  style="padding-left:1.1pt;padding-Right:1.1pt;padding-Top:1.1pt;padding-Bottom:1.1pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="cytx-ex101_7.htm"><font style="text-decoration:underline;">Sales Agreement, dated June 1, 2018, by and between Cytori Therapeutics, Inc. and B. Riley FBR, Inc.</font></a></p></td>
</tr>
<tr>
<td valign="top"  style="padding-left:1.1pt;padding-Right:1.1pt;padding-Top:1.1pt;padding-Bottom:1.1pt;width:auto;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23.1</p></td>
<td valign="top"  style="padding-left:1.1pt;padding-Right:1.1pt;padding-Top:1.1pt;padding-Bottom:1.1pt;width:auto;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom"  style="padding-left:1.1pt;padding-Right:1.1pt;padding-Top:1.1pt;padding-Bottom:1.1pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="cytx-ex51_6.htm"><font style="text-decoration:underline;">Consent of Latham &amp; Watkins LLP (included in Exhibit 5.1)</font></a></p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU4"></a><br /></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">SIGNATURES</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:49.81%;"></td>
<td style="width:50.19%;"></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">CYTORI THERAPEUTICS, INC.</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle"  style=" border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date:&nbsp;&nbsp;June 1, 2018</p></td>
<td valign="top"  style=" border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By: /s/ Tiago Girao</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tiago Girao</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">VP Finance and Chief Financial Officer </p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>cytx-ex51_6.htm
<DESCRIPTION>EX-5.1
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
cytx-ex51_6.htm
</title>
</head>
<!-- NG Converter v5.0.18092.123 -->
<body>

<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT 5.1</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g201806011825106681022.jpg" title="" alt="" style="width:237px;height:16px;"></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>&nbsp;</p>
<p style="text-align:center;line-height:11pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12670 High Bluff Drive</p>
<p style="text-align:center;line-height:11pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">San Diego, California 92130</p>
<p style="text-align:center;line-height:11pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tel: +1.858.523.5400&nbsp;&nbsp;Fax: +1.858.523.5450</p>
<p style="text-align:center;margin-bottom:5pt;line-height:11pt;margin-top:0pt;text-indent:0%;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">www.lw.com</p>
<p style="text-align:center;line-height:11pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">FIRM / AFFILIATE OFFICES</p>
<p style="text-align:center;line-height:11pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Beijing<font style="margin-left:36pt;">Moscow</font></p>
<p style="text-align:center;line-height:11pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Boston<font style="margin-left:36pt;"></font>Munich</p>
<p style="text-align:center;line-height:11pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Brussels<font style="margin-left:36pt;"></font>New York</p>
<p style="text-align:center;line-height:11pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Century City<font style="margin-left:36pt;"></font>Orange County</p>
<p style="text-align:center;line-height:11pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chicago<font style="margin-left:36pt;">Paris</font></p>
<p style="text-align:center;line-height:11pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dubai<font style="margin-left:36pt;"></font>Riyadh</p>
<p style="text-align:center;line-height:11pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">D&#252;sseldorf<font style="margin-left:36pt;">Rome</font></p>
<p style="text-align:center;line-height:11pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Frankfurt<font style="margin-left:36pt;"></font>San Diego</p>
<p style="text-align:center;line-height:11pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Hamburg<font style="margin-left:36pt;"></font>San Francisco</p>
<p style="text-align:center;line-height:11pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Hong Kong<font style="margin-left:36pt;"></font>Seoul</p>
<p style="text-align:center;line-height:11pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Houston<font style="margin-left:36pt;">Shanghai</font></p>
<p style="text-align:center;line-height:11pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">London<font style="margin-left:36pt;"></font>Silicon Valley</p>
<p style="text-align:center;line-height:11pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Los Angeles<font style="margin-left:36pt;"></font>Singapore</p>
<p style="text-align:center;line-height:11pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Madrid<font style="margin-left:36pt;">Tokyo</font></p>
<p style="text-align:center;line-height:11pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Milan<font style="margin-left:36pt;"></font>Washington, D.C.</p>
<p style="text-align:center;line-height:11pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">June 1, 2018</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><a name="SDP"></a>&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cytori Therapeutics, Inc. </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3020 Callan Road</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">San Diego, CA 92121</p>
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Re:</font></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><font style="text-decoration:underline;">Cytori Therapeutics, Inc.</font></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Ladies and Gentlemen:</p>
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have acted as special counsel to Cytori Therapeutics, Inc., a Delaware corporation (the &#8220;<font style="font-weight:bold;font-style:italic;">Company</font>&#8221;), in connection with<sup style="font-size:85%; vertical-align:top"> </sup>the sale through B. Riley FBR, Inc. (&#8220;<font style="font-weight:bold;font-style:italic;">FBR</font>&#8221;) as the sales agent from time to time by the Company of shares of the common stock of the Company, par value $0.001 per share (the &#8220;<font style="font-weight:bold;font-style:italic;">Common Stock</font>&#8221;), having an aggregate offering price of up to $6,500,000 (the &#8220;<font style="font-weight:bold;font-style:italic;">Shares</font>&#8221;), to be issued pursuant to a registration statement on Form S-3 filed by the Company with the Securities and Exchange Commission (the &#8220;<font style="font-weight:bold;font-style:italic;">Commission</font>&#8221;) on May 12, 2017 (Registration No. 333-217988) (as amended, the &#8220;<font style="font-weight:bold;font-style:italic;">Registration Statement</font>&#8221;), the base prospectus included in the Registration Statement (the &#8220;<font style="font-weight:bold;font-style:italic;">Base Prospectus</font>&#8221;) and a prospectus supplement dated June 1, 2018 filed with the Commission pursuant to Rule 424(b) of the Securities Act of 1933, as amended (the &#8220;<font style="font-weight:bold;font-style:italic;">Act</font>&#8221;) (together with the Base Prospectus, the &#8220;<font style="font-weight:bold;font-style:italic;">Prospectus</font>&#8221;), and that certain Sales Agreement, dated as of June 1, 2018, by and between the Company and FBR (the &#8220;<font style="font-weight:bold;font-style:italic;">Sales Agreement</font>&#8221;).</p>
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The term &#8220;<font style="font-weight:bold;font-style:italic;">Shares</font>&#8221; shall include any additional shares of common stock registered by the Company pursuant to Rule 462(b) under the Act, in connection with the offering contemplated by the Registration Statement.&nbsp;&nbsp;This opinion is being furnished in connection with the requirements of Item 601(b)(5) of Regulation S-K under the Act, and no opinion is expressed herein as to any matter pertaining to the contents of the Registration Statement or the Prospectus, other than as expressly stated herein with respect to the issue of the Shares.</p>
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As such counsel, we have examined such matters of fact and questions of law as we have considered appropriate for purposes of this letter.&nbsp;&nbsp;With your consent, we have relied upon certificates and other assurances of officers of the Company and others as to factual matters without having independently verified such factual matters.&nbsp;&nbsp;We are opining herein as to the General Corporation Law of the State of Delaware (the &#8220;<font style="font-weight:bold;font-style:italic;">DGCL</font>&#8221;), and we express no opinion with respect to any other laws.</p>
<p style="margin-bottom:6pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:473.4pt;;">
<tr>
<td style="width:473.4pt;"></td>
</tr>
<tr style="height:27.2pt;">
<td valign="top" >
<p style="line-height:8pt;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Times New Roman;"><a name="LetterheadPg2Placeholder"></a><a name="SmallLogo_NewYork"></a><a name="SmallLogo_NorthernVirginia"></a><a name="SmallLogo_OrangeCounty"></a><a name="SmallLogo_SanDiego"></a><a name="SmallLogo_SanDiegoNorthCounty"></a><a name="SmallLogo_SanFrancisco"></a><a name="SmallLogo_LosAngeles"></a><a name="SmallLogo_SiliconValley"></a><a name="SmallLogo_NewJersey"></a><a name="SmallLogo_WashingtonDC"></a><a name="SmallLogo_Singapore"></a><a name="SmallLogo_UniversalCity"></a><a name="SmallLogo_Brussels"></a><a name="SmallLogo_GlobalServicesOffice"></a><a name="SmallLogo_Chicago"></a><a name="SmallLogo_Moscow"></a><a name="SmallLogo_Frankfurt"></a><a name="SmallLogo_Hamburg"></a><a name="SmallLogo_GSOe"></a><a name="SmallLogo_Shanghai"></a><a name="SmallLogo_Munich"></a><a name="SmallLogo_Barcelona"></a><a name="SmallLogo_Madrid"></a><a name="SmallLogo_Dubai"></a><a name="SmallLogo_Doha"></a><a name="SmallLogo_AbuDhabi"></a><a name="SmallLogo_Beijing"></a><a name="SmallLogo_Houston"></a><a name="SmallLogo_Boston"></a><a name="SmallLogo_BostonWaltham"></a><a name="SmallLogo_D&#252;sseldorf"></a><a name="SmallLogo_FrankfurtGerichtsfach"></a><a name="LabelLogo_FrankfurtGerichtsfach"></a><a name="SmallLogo_CenturyCity"></a><a name="SmallLogo_Seoul"></a>&nbsp;</p></td>
</tr>
</table></div>
<p style="margin-bottom:18pt;margin-top:5pt;text-indent:0%;font-weight:bold;font-size:6.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><img src="g201806011825107951022.jpg" title="" alt="" style="width:162px;height:10px;"></p>
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU2"></a><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Subject to the foregoing and the other matters set forth herein, it is our opinion that</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, as of the date hereof,</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">when the Shares shall have been duly registered on the books of the transfer agent and registrar therefor in the name or on behalf of the purchasers, and have been issued by the Company against payment therefor (not less than par value) in the circumstances contemplated by the </font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sales </font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Agreement, the issue and sale of the Shares will have been duly authorized by all necessary corporate action of the Company, and the Shares</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">will be validly issued, fully paid and nonassessable.&nbsp;&nbsp;In rendering the foregoing opinion, we have assumed that </font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(i)&#160;</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the Company will comply with all applicable notice requirements regarding uncertificated shares provided in the DGCL</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and (ii)&#160;upon the issue</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of any of the Shares, the total number of shares of Common Stock issued and outstanding will not exceed the total number of shares of Common Stock that the Company is then authorized to issue under its Amended and Restated Certificate of Incorporation</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p>
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This opinion is for your benefit in connection with the Registration Statement and may be relied upon by you and by persons entitled to rely upon it pursuant to the applicable provisions of the Act.&nbsp;&nbsp;We consent to your filing this opinion as an exhibit to the Company&#8217;s Current Report on Form 8-K dated June 1, 2018 and to the reference to our firm in the Prospectus under the heading &#8220;Legal Matters.&#8221;&nbsp;&nbsp;In giving such consent, we do not thereby admit that we are in the category of persons whose consent is required under Section&#160;7 of the Act or the rules and regulations of the Commission thereunder.</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:46.15%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Very truly yours, </p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:46.15%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:46.15%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Latham &amp; Watkins LLP</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:46.15%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:46.15%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:46.15%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>3
<FILENAME>cytx-ex101_7.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
cytx-ex101_7.htm
</title>
</head>
<!-- NG Converter v5.0.18092.123 -->
<body>

<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT 10.1</p>
<p style="text-align:center;margin-bottom:5pt;margin-top:0pt;text-indent:0%;font-weight:bold;text-transform:uppercase;font-size:12pt;font-family:Times New Roman;font-style:normal;font-variant: normal;">CYTORI THERAPEUTICS, INC.</p>
<p style="text-align:center;margin-bottom:5pt;margin-top:0pt;text-indent:0%;font-weight:bold;text-transform:uppercase;font-size:12pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:underline;"><br />SALES AGREEMENT<br /></font></p>
<p style="text-align:right;margin-bottom:5pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">June 1, 2018</p>
<p style="text-align:center;margin-bottom:5pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">B. Riley FBR, Inc.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">299 Park Avenue, 7<sup style="font-size:85%; vertical-align:top">th</sup> Floor</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">New York, NY 10171</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Ladies and Gentlemen:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cytori Therapeutics, Inc. (the &#8220;<font style="font-weight:bold;text-decoration:underline;">Company</font>&#8221;), confirms its agreement (this &#8220;<font style="font-weight:bold;text-decoration:underline;">Agreement</font>&#8221;) with B. Riley FBR, Inc. (&#8220;<font style="font-weight:bold;text-decoration:underline;">Agent</font>&#8221;), as follows:</p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.&#160;&#160;<font style="margin-left:72pt;"></font><font style="text-decoration:underline;color:#000000;">Issuance and Sale of Shares</font><font style="color:#000000;">.&nbsp;&nbsp;The Company agrees that, from time to time during the term of this Agreement, on the terms and subject to the conditions set forth herein, it may issue and sell through the Agent, acting as agent and/or principal, shares of the Company&#8217;s common stock, par value $0.001 per share (the &#8220;</font><font style="font-weight:bold;text-decoration:underline;color:#000000;">Common Stock</font><font style="color:#000000;">&#8221;); provided however, that in no event shall the Company issue or sell through the Agent such number of Placement Shares (as defined below) that (i) would cause the Company not to satisfy the eligibility requirements for use of Form S-3 (including instruction I.B.6 thereof), (ii) exceeds the number of shares of Common Stock registered on the effective Registration Statement (as defined below) pursuant to which the offering is being made, or (iii) exceeds the number of authorized but unissued shares of Common Stock. Notwithstanding anything to the contrary contained herein, the parties hereto agree that compliance with the limitation set forth in this </font><font style="text-decoration:underline;color:#000000;">Section 1</font><font style="color:#000000;"> on the number of shares of Common Stock issued and sold under this Agreement shall be the sole responsibility of the Company, and the Agent shall have no obligation in connection with such compliance.&nbsp;&nbsp;The issuance and sale of Common Stock through the Agent will be effected pursuant to the Registration Statement (as defined below) filed by the Company and declared effective by the Securities and Exchange Commission (the &#8220;</font><font style="font-weight:bold;text-decoration:underline;color:#000000;">Commission</font><font style="color:#000000;">&#8221;), although nothing in this Agreement shall be construed as requiring the Company to use the Registration Statement (as defined below) to issue the Common Stock.&nbsp;&nbsp;</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU2"></a>The Company has filed, in accordance with the provisions of the Securities Act of 1933, as amended, and the rules and regulations thereunder (collectively, the &#8220;<font style="font-weight:bold;text-decoration:underline;">Securities Act</font>&#8221;), with the Commission a registration statement on Form S-3 (File No. 333-217988), including a base prospectus, relating to certain securities, including the Common Stock, to be issued from time to time by the Company, and which incorporates by reference documents that the Company has filed or will file in accordance with the provisions of the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder (collectively, the &#8220;<font style="font-weight:bold;text-decoration:underline;">Exchange Act</font>&#8221;). The Company has prepared a prospectus supplement specifically relating to the Common Stock being offered under this Agreement (the &#8220;<font style="font-weight:bold;text-decoration:underline;">Prospectus Supplement</font>&#8221;) to the base prospectus included as part of such registration statement.&nbsp;&nbsp;The Company has furnished to the Agent, for use by the Agent, copies of the prospectus included as part of such registration statement, as supplemented by the Prospectus Supplement, relating to the Common Stock.&nbsp;&nbsp;Except where the context otherwise requires, such </p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT 10.1</p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">registration statement, as amended when it became effective, including all documents filed as part thereof or incorporated by reference therein, and including any information contained in a Prospectus (as defined below) subsequently filed with the Commission pursuant to Rule 424(b) under the Securities Act or deemed to be a part of such registration statement pursuant to Rule 430B or 462(b) of the Securities Act, is herein called the &#8220;</font><font style="font-weight:bold;text-decoration:underline;">Registration Statement.</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221;&nbsp;&nbsp;The base prospectus, including all documents incorporated therein by reference, included in the Registration Statement, as it may be supplemented by the Prospectus Supplement, in the form in which such prospectus and/or Prospectus Supplement have most recently been filed by the Company with the Commission pursuant to Rule 424(b) under the Securities Act, together with any &#8220;issuer free writing prospectus,&#8221; as defined in Rule 433 of the Securities Act Regulations (&#8220;</font><font style="font-weight:bold;text-decoration:underline;">Rule 433</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221;), relating to the Common Stock</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">offered under this Agreement&nbsp;&nbsp;that (i) is required to be filed with the Commission by the Company or (ii) is exempt from filing pursuant to Rule 433(d)(5)(i), in each case in the form filed or required to be filed with the Commission or, if not required to be filed, in the form retained in the Company&#8217;s records pursuant to Rule 433(g), is herein called the &#8220;</font><font style="font-weight:bold;text-decoration:underline;">Prospectus</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&#8221; Any reference herein to the Registration Statement, the Prospectus or any amendment or supplement thereto shall be deemed to refer to and include the documents incorporated by reference therein, and any reference herein to the terms &#8220;amend,&#8221; &#8220;amendment&#8221; or &#8220;supplement&#8221; with respect to the Registration Statement or the Prospectus shall be deemed to refer to and include the filing after the execution hereof of any document with the Commission deemed to be incorporated by reference therein. For purposes of this Agreement, all references to the Registration Statement, the Prospectus or to any amendment or supplement thereto shall be deemed to include any copy filed with the Commission pursuant to either the Electronic Data Gathering Analysis and Retrieval System or Interactive Data Electronic Applications (collectively &#8220;</font><font style="font-weight:bold;text-decoration:underline;">IDEA</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221;).</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU3"></a>2.&#160;&#160;<font style="margin-left:72pt;"></font><font style="text-decoration:underline;color:#000000;">Placements</font><font style="color:#000000;">.&nbsp;&nbsp;Each time that the Company wishes to issue and sell the Common Stock hereunder (each, a &#8220;</font><font style="font-weight:bold;text-decoration:underline;color:#000000;">Placement</font><font style="color:#000000;">&#8221;), it will notify the Agent by email notice (or other method mutually agreed to in writing by the parties) (a &#8220;</font><font style="font-weight:bold;text-decoration:underline;color:#000000;">Placement Notice</font><font style="color:#000000;">&#8221;) containing the parameters in accordance with which it desires the shares of Common Stock to be sold, which shall at a minimum include the number of shares of Common Stock to be issued (the &#8220;</font><font style="font-weight:bold;text-decoration:underline;color:#000000;">Placement Shares</font><font style="color:#000000;">&#8221;), the time period during which sales are requested to be made, any limitation on the number of shares of Common Stock that may be sold in any one Trading Day (as defined in Section 3) and any minimum price below which sales may not be made, a form of which containing such minimum sales parameters necessary is attached hereto as </font><font style="font-weight:bold;text-decoration:underline;color:#000000;">Schedule 1</font><font style="color:#000000;">.&nbsp;&nbsp;The Placement Notice shall originate from any of the individuals from the Company set forth on </font><font style="font-weight:bold;text-decoration:underline;color:#000000;">Schedule 2</font><font style="font-weight:bold;color:#000000;"> </font><font style="color:#000000;">(with a copy to each of the other individuals from the Company listed on such schedule), and shall be addressed to each of the individuals from the Agent set forth on </font><font style="font-weight:bold;text-decoration:underline;color:#000000;">Schedule 2</font><font style="color:#000000;">, as such </font><font style="font-weight:bold;text-decoration:underline;color:#000000;">Schedule 2</font><font style="color:#000000;"> may be amended from time to time. The Placement Notice shall be effective upon receipt by the Agent unless and until (i) in accordance with the notice requirements set forth in Section 4, the Agent declines to accept the terms contained therein for any reason, in its sole discretion, (ii) the entire amount of the Placement Shares have been sold, (iii) in accordance with the notice requirements set forth in </font><font style="text-decoration:underline;color:#000000;">Section 4</font><font style="color:#000000;">, the Company suspends or terminates the Placement Notice for any reason, in its sole discretion, (iv) the Company issues a subsequent Placement Notice with parameters superseding those on the earlier dated Placement Notice, or (v) the Agreement has been terminated under the provisions of </font><font style="text-decoration:underline;color:#000000;">Section 11</font><font style="color:#000000;">.&nbsp;&nbsp; The amount of any discount, commission or other compensation to be paid by the Company to the Agent in connection with the sale of the Placement Shares shall be calculated in accordance with the terms set forth in </font><font style="font-weight:bold;text-decoration:underline;color:#000000;">Schedule 3</font><font style="font-weight:bold;color:#000000;">.</font><font style="color:#000000;">&nbsp;&nbsp;It is expressly acknowledged and </font></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT 10.1</p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="color:#000000;">agreed that neither the Company nor the Agent will have any obligation whatsoever with respect to a Placement or any Placement Shares unless and until the Company delivers a Placement Notice to the Agent and the Agent does not decline such Placement Notice pursuant to the terms set forth above, and then only upon the terms specified therein and herein.&nbsp;&nbsp;In the event of a conflict between the terms of this Agreement and the terms of a Placement Notice, the terms of the Placement Notice will control.</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.&#160;&#160;<font style="margin-left:72pt;"></font><font style="text-decoration:underline;color:#000000;">Sale of Placement Shares by the Agent.</font><font style="color:#000000;">&nbsp;&nbsp;Subject to the terms and conditions herein set forth, upon the Company&#8217;s issuance of a Placement Notice, and unless the sale of the Placement Shares described therein has been declined, suspended, or otherwise terminated in accordance with the terms of this Agreement, the Agent, for the period specified in the Placement Notice, will use its commercially reasonable efforts consistent with its normal trading and sales practices and applicable state and federal laws, rules and regulations and the rules of the Nasdaq Stock Market LLC (the &#8220;</font><font style="font-weight:bold;text-decoration:underline;color:#000000;">Exchange</font><font style="color:#000000;">&#8221;) to sell such Placement Shares up to the amount specified, and otherwise in accordance with the terms of such Placement Notice.&nbsp;&nbsp;The Agent will provide written confirmation to the Company (including by email correspondence to each of the individuals of the Company set forth on </font><font style="font-weight:bold;text-decoration:underline;color:#000000;">Schedule 2</font><font style="color:#000000;">, if receipt of such correspondence is actually acknowledged by any of the individuals to whom the notice is sent, other than via auto-reply) no later than the opening of the Trading Day (as defined below) immediately following the Trading Day on which it has made sales of Placement Shares hereunder setting forth the number of Placement Shares sold on such day, the price per share at which each sale of Placement Shares occurs on such day, the compensation payable by the Company to the Agent pursuant to </font><font style="font-weight:bold;text-decoration:underline;color:#000000;">Section 2</font><font style="color:#000000;"> with respect to such sales, and the Net Proceeds (as defined below) payable to the Company, with an itemization of the deductions made by the Agent (as set forth in Section 5(a)) from the gross proceeds that it receives from such sales.&nbsp;&nbsp;The Agent may sell Placement Shares by any method permitted by law deemed to be an &#8220;at the market&#8221; offering as defined in Rule 415 of the Securities Act.&nbsp;&nbsp;Notwithstanding the provisions of Section 6(cc), the Agent shall not purchase Placement Shares for its own account as principal unless expressly authorized to do so by the Company in a Placement Notice.&nbsp;&nbsp;The Company acknowledges and agrees that (i) there can be no assurance that the Agent will be successful in selling Placement Shares, and (ii) the Agent will incur no liability or obligation to the Company or any other person or entity if it does not sell Placement Shares for any reason other than a failure by the Agent to use its commercially reasonable efforts consistent with its normal trading and sales practices to sell such Placement Shares as required under this </font><font style="text-decoration:underline;color:#000000;">Section 3</font><font style="color:#000000;">.&nbsp;&nbsp;For the purposes hereof, &#8220;</font><font style="font-weight:bold;text-decoration:underline;color:#000000;">Trading Day</font><font style="color:#000000;">&#8221; means any day on which the Company&#8217;s Common Stock is purchased and sold on the principal market on which the Common Stock is listed or quoted.</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.&#160;&#160;<font style="margin-left:72pt;"></font><font style="text-decoration:underline;color:#000000;">Suspension of Sales</font><font style="color:#000000;">.&nbsp;&nbsp;</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU4"></a>(a)<font style="margin-left:36pt;">The Company or the Agent may, upon notice to the other party in writing (including by email correspondence to each of the individuals of the other party set forth on </font><font style="font-weight:bold;text-decoration:underline;">Schedule 2</font>, if receipt of such correspondence is actually acknowledged by any of the individuals to whom the notice is sent, other than via auto-reply) or by telephone (confirmed immediately by verifiable facsimile transmission or email correspondence to each of the individuals of the other party set forth on <font style="font-weight:bold;text-decoration:underline;">Schedule 2</font>), suspend any sale of Placement Shares; <font style="font-style:italic;">provided, however</font>, that such suspension shall not affect or impair either party&#8217;s obligations with respect to any Placement Shares sold hereunder prior to the receipt of such notice.&nbsp;&nbsp;Each of the Parties agrees that no such </p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT 10.1</p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">notice under this </font><font style="text-decoration:underline;">Section 4</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> shall be effective against the other unless it is made to one of the individuals named on </font><font style="font-weight:bold;text-decoration:underline;">Schedule 2</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> hereto, as such schedule may be amended from time to time.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">(b)<font style="margin-left:36pt;">Notwithstanding any other provision of this Agreement, during any period in which the Company is in possession of material non-public information, the Company and the Agent agree that (i) no sale of Placement Shares will take place, (ii) the Company shall not request the sale of any Placement Shares, and (iii) the Agent shall not be obligated to sell or offer to sell any Placement Shares.</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">(c)<font style="margin-left:36pt;">If either the Agent or the Company has reason to believe that the exemptive provisions set forth in Rule 101(c)(1) of Regulation M under the Exchange Act are not satisfied with respect to the Common Stock, it shall promptly notify the other party, and the Agent may, at its sole discretion, suspend sales of the Placement Shares under this Agreement.&nbsp;&nbsp;</font>The Agent shall calculate on a weekly basis the average daily trading volume (as defined by Rule 100 of Regulation M under the Exchange Act) of the Common Stock.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.&#160;&#160;<font style="margin-left:72pt;"></font><font style="text-decoration:underline;color:#000000;">Settlement.</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Settlement of Placement Shares</font><font style="color:#000000;">.&nbsp;&nbsp;Unless otherwise specified in the applicable Placement Notice, settlement for sales of Placement Shares will occur on the second (2<sup style="font-size:85%; vertical-align:top">nd</sup>) Trading Day (or such earlier day as is industry practice for regular-way trading) following the date on which such sales are made (each, a &#8220;</font><font style="font-weight:bold;text-decoration:underline;color:#000000;">Settlement Date</font><font style="color:#000000;">&#8221;).&nbsp;&nbsp;The amount of proceeds to be delivered to the Company on a Settlement Date against receipt of the Placement Shares sold (the &#8220;</font><font style="font-weight:bold;text-decoration:underline;color:#000000;">Net Proceeds</font><font style="color:#000000;">&#8221;) will be equal to the aggregate sales price received by the Agent at which such Placement Shares were sold, after deduction for (i)&#160;the Agent&#8217;s commission, discount or other compensation for such sales payable by the Company pursuant to </font><font style="text-decoration:underline;color:#000000;">Section 2</font><font style="color:#000000;"> hereof, (ii) any other amounts due and payable by the Company to the Agent hereunder pursuant to </font><font style="text-decoration:underline;color:#000000;">Section 7(g)</font><font style="color:#000000;"> (Expenses) hereof, and (iii) any transaction fees imposed by any governmental or self-regulatory organization in respect of such sales.&nbsp;&nbsp; </font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Delivery of Placement Shares</font><font style="color:#000000;">.&nbsp;&nbsp;On or before each Settlement Date, the Company will, or will cause its transfer agent to, electronically transfer the Placement Shares being sold by crediting the Agent&#8217;s or its designee&#8217;s account (provided the Agent shall have given the Company written notice of such designee prior to the Settlement Date) at The Depository Trust Company through its Deposit and Withdrawal at Custodian System or by such other means of delivery as may be mutually agreed upon by the parties hereto which in all cases shall be freely tradeable, transferable, registered shares in good deliverable form.&nbsp;&nbsp;On each Settlement Date, the Agent will deliver the related Net Proceeds in same day funds to an account designated by the Company on, or prior to, the Settlement Date.&nbsp;&nbsp;The Company agrees that if the Company, or its transfer agent (if applicable), defaults in its obligation to deliver duly authorized Placement Shares on a Settlement Date, the Company agrees that in addition to and in no way limiting the rights and obligations set forth in </font><font style="text-decoration:underline;color:#000000;">Section 9(a)</font><font style="color:#000000;"> (Indemnification and Contribution) hereto, it will (i)&#160;hold the Agent harmless against any loss, claim, damage, or expense (including reasonable legal fees and expenses), as incurred, arising out of or in connection with such default by the Company and (ii) pay to the Agent any commission, discount, or other compensation to which it would otherwise have been entitled absent such default.</font></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT 10.1</p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU5"></a><font style="color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.&#160;&#160;</font><font style="margin-left:72pt;"></font><font style="text-decoration:underline;color:#000000;">Representations and Warranties of the Company</font><font style="color:#000000;">.&nbsp;&nbsp;The Company represents and warrants to, and agrees with, the Agent that, unless such representation or warranty specifies otherwise, as of the date of this Agreement and as of each Applicable Time (as defined in </font><font style="text-decoration:underline;color:#000000;">Section 20(a)</font><font style="color:#000000;">): </font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Compliance with Registration Requirements</font><font style="color:#000000;">. The Registration Statement and any Rule&#160;462(b) Registration Statement have been declared effective by the Commission under the Securities Act.&nbsp;&nbsp;The Company has complied to the Commission&#8217;s satisfaction with all requests of the Commission for additional or supplemental information with respect to the Registration Statement.&nbsp;&nbsp;No stop order suspending the effectiveness of the Registration Statement or any Rule&#160;462(b) Registration Statement is in effect and no proceedings for such purpose have been instituted or are pending or, to the knowledge of the Company, are contemplated or threatened by the Commission.&nbsp;&nbsp;At the time the Registration Statement was declared effective, and at the time the Company&#8217;s most recent Annual Report on Form 10-K was filed with the Commission, the Company met or will meet the then applicable requirements for the use of Form S-3 under the Securities Act, including, but not limited to, General Instruction I.B.6 of Form S-3, if applicable.&nbsp;&nbsp;As of the close of trading on the Exchange on May 10, 2018, the aggregate market value of the outstanding voting and non-voting common equity (as defined in Rule 405) of the Company held by persons other than affiliates of the Company (pursuant to Rule 144 of the Securities Act, those that directly, or indirectly through one or more intermediaries, control, or are controlled by, or are under common control with, the Company)&nbsp;&nbsp;(the &#8220;Non-Affiliate Shares&#8221;), was approximately $19.5 million (calculated by multiplying (x) the price at which the common equity of the Company was last sold on the Exchange on May 10, 2018 times (y) the number of Non-Affiliate Shares). The Company is not a shell company (as defined in Rule 405 under the Securities Act) and has not been a shell company for at least 12 calendar months previously and if it has been a shell company at any time previously, has filed current Form 10 information (as defined in General Instruction I.B.6 of Form S-3) with the Commission at least 12 calendar months previously reflecting its status as an entity that is not a shell company. </font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">No Misstatement or Omission</font><font style="color:#000000;">.&nbsp;&nbsp;The Prospectus when filed complied and, as amended or supplemented, if applicable, will comply in all material respects with the Securities Act.&nbsp;&nbsp;Each of the Registration Statement, any Rule&#160;462(b) Registration Statement and any post-effective amendment thereto, at the time it became effective, complied and, as of each of the Settlement Dates, if any, will comply in all material respects with the Securities Act and did not and, as of each of the Settlement Dates, if any, will not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements therein not misleading. The Prospectus, as amended or supplemented, as of its date, did not and, as of each of the Settlement Dates, if any, will not contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. The representations and warranties set forth in the two immediately preceding sentences do not apply to statements in or omissions from the Registration Statement, any Rule&#160;462(b) Registration Statement, or any post-effective amendment thereto, or the Prospectus, or any amendments or supplements thereto, made in reliance upon and in conformity with information relating to the Agent furnished to the Company in writing by the Agent expressly for use therein.&nbsp;&nbsp;There are no contracts or other documents required to be described in the Prospectus or to be filed as exhibits to the Registration Statement which have not been described or filed as required.</font></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT 10.1</p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU6"></a><font style="color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)&#160;</font><font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Offering Materials Furnished to the Agent</font><font style="color:#000000;">. The Company has delivered to the Agent one complete copy of the Registration Statement and a copy of each consent and certificate of experts filed as a part thereof, and conformed copies of the Registration Statement (without exhibits) and the Prospectus, as amended or supplemented, in such quantities and at such places as the Agent has reasonably requested.</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Distribution of Offering Material By the Company</font><font style="color:#000000;">. The Company has not distributed and will not distribute, prior to the completion of the Agent&#8217;s distribution of the Common Stock issued and sold under this Agreement, any offering material in connection with the offering and sale of the Common Stock issued and sold under this Agreement other than the Prospectus or the Registration Statement.</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(e)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">The Sales Agreement</font><font style="color:#000000;">. This Agreement has been duly authorized, executed and delivered by, and is a valid and binding agreement of, the Company, enforceable in accordance with its terms, except as rights to indemnification hereunder may be limited by applicable law and except as the enforcement hereof may be limited by bankruptcy, insolvency, reorganization, moratorium or other similar laws relating to or affecting the rights and remedies of creditors or by general equitable principles.&nbsp;&nbsp;</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(f)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Authorization of the Common Stock</font><font style="color:#000000;">. The shares of Common Stock to be sold by the Agent under this Agreement, acting as agent and/or principal for the Company, have been duly authorized for issuance and sale pursuant to this Agreement and, when issued and delivered by the Company to the Agent pursuant to this Agreement, will be validly issued, fully paid and nonassessable.</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(g)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">No Applicable Registration or Other Similar Rights</font><font style="color:#000000;">. There are no persons with registration or other similar rights to have any equity or debt securities registered for sale under the Registration Statement or included in the offering contemplated by this Agreement, except for such rights as have been duly waived.&nbsp;&nbsp;</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(h)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">No Material Adverse Change</font><font style="color:#000000;">.&nbsp;&nbsp;Except as otherwise disclosed in the Prospectus, subsequent to the respective dates as of which information is given in the Prospectus: (i)&#160;there has been no material adverse change, or any development that would reasonably be expected to result in a material adverse change, in the condition, financial or otherwise, or in the results of operations, business, operations or prospects, whether or not arising from transactions in the ordinary course of business, of the Company and its subsidiaries, considered as one entity (any such change is called a &#8220;</font><font style="font-weight:bold;text-decoration:underline;color:#000000;">Material Adverse Change</font><font style="color:#000000;">&#8221;); (ii)&#160;the Company and its subsidiaries, considered as one entity, have not incurred any material liability or obligation, direct or contingent, not in the ordinary course of business nor entered into any material transaction or agreement not in the ordinary course of business: and (iii)&#160;there has been no dividend or distribution of any kind declared, paid or made by the Company or, except for regular quarterly dividends publicly announced by the Company or dividends paid to the Company or other subsidiaries, any of its subsidiaries on any class of capital stock or repurchase or redemption by the Company or any of its subsidiaries of any class of capital stock.</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU7"></a>(i)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Independent Accountants</font><font style="color:#000000;">.&nbsp;&nbsp;BDO USA, LLP, who have expressed their opinion with respect to the financial statements (which term as used in this Agreement includes the related notes thereto) and supporting schedules included in the Company&#8217;s Form 10-K for the fiscal year ended </font></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT 10.1</p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="color:#000000;">December 31, 2017, filed with the Commission or incorporated by reference as a part of the Registration Statement and included in the Prospectus, is an independent registered public accounting firm as required by the Securities Act and the Exchange Act.&nbsp;&nbsp;</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(j)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Preparation of the Financial Statements</font><font style="color:#000000;">. The financial statements filed with the Commission as a part of or incorporated by reference in the Registration Statement and included in the Prospectus present fairly in all material respects the consolidated financial position of the Company and its subsidiaries as of and at the dates indicated therein and the results of their operations and cash flows for the periods specified.&nbsp;&nbsp;Such financial statements have been prepared in accordance with generally accepted accounting principles in the United States applied on a consistent basis throughout the periods involved, except as may be expressly stated in the related notes thereto.&nbsp;&nbsp;No other financial statements or supporting schedules are required to be included in or incorporated in the Registration Statement.&nbsp;&nbsp;</font><font style="margin-left:36pt;color:#000000;"></font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(k)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Incorporation and Good Standing of the Company</font><font style="color:#000000;">. The Company has been duly incorporated and is validly existing as a corporation in good standing under the laws of the State of Delaware and has corporate power and authority to own, lease and operate its properties and to conduct its business as described in the Prospectus and to enter into and perform its obligations under this Agreement.&nbsp;&nbsp;The Company is duly qualified as a foreign corporation or foreign partnership to transact business and is in good standing in the State of California and each other jurisdiction in which such qualification is required, whether by reason of the ownership or leasing of property or the conduct of business, except for such jurisdictions (other than the State of California) where the failure to so qualify or to be in good standing would not, individually or in the aggregate, result in a Material Adverse Change.&nbsp;&nbsp;The Company does not own or control, directly or indirectly, any corporation, association or other entity other than the subsidiaries listed in Exhibit&#160;21.1 to the Company&#8217;s most recent Annual Report on Form&#160;10-K and other than (i)&#160;those subsidiaries not required to be listed on Exhibit&#160;21.1 by Item&#160;601 of Regulation S-K under the Exchange Act and (ii)&#160;those subsidiaries formed since the last day of the most recently ended fiscal year.&nbsp;&nbsp;</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(l)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Capital Stock Matters</font><font style="color:#000000;">. The Common Stock conforms in all material respects to the description thereof contained in the Prospectus.&nbsp;&nbsp;All of the issued and outstanding shares of Common Stock have been duly authorized and validly issued, are fully paid and nonassessable and have been issued in compliance with federal and state securities laws.&nbsp;&nbsp;None of the outstanding shares of Common Stock were issued in violation of any preemptive rights, rights of first refusal or other similar rights to subscribe for or purchase securities of the Company.&nbsp;&nbsp;There are no authorized or outstanding options, warrants, preemptive rights, rights of first refusal or other rights to purchase, or equity or debt securities convertible into or exchangeable or exercisable for, any capital stock of the Company or any of its subsidiaries other than those accurately described in all material respects in the Prospectus.&nbsp;&nbsp;The description of the Company&#8217;s stock option, stock bonus and other stock plans or arrangements, and the options or other rights granted thereunder, set forth in the Prospectus accurately and fairly presents in all material respects the information required to be shown with respect to such plans, arrangements, options and rights.&nbsp;&nbsp;</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU8"></a>(m)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Non-Contravention of Existing Instruments; No Further Authorizations or Approvals Required</font><font style="color:#000000;">.&nbsp;&nbsp; Neither the Company nor any of its subsidiaries is in violation of its charter or by-laws or is in default (or, with the giving of notice or lapse of time, would be in default) (&#8220;</font><font style="font-weight:bold;text-decoration:underline;color:#000000;">Default</font><font style="color:#000000;">&#8221;) under any indenture, mortgage, loan or credit agreement, note, contract, franchise, </font></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT 10.1</p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="color:#000000;">lease or other instrument to which the Company or any of its subsidiaries is a party or by which it or any of them may be bound, or to which any of the property or assets of the Company or any of its subsidiaries is subject (each, an &#8220;</font><font style="font-weight:bold;text-decoration:underline;color:#000000;">Existing Instrument</font><font style="color:#000000;">&#8221;), except for such Defaults as would not, individually or in the aggregate, result in a Material Adverse Change.&nbsp;&nbsp;The Company&#8217;s execution, delivery and performance of this Agreement and consummation of the transactions contemplated hereby (i)&#160;have been duly authorized by all necessary corporate action and will not result in any violation of the provisions of the charter or by-laws of the Company or any subsidiary, (ii)&#160;will not conflict with or constitute a breach of, or Default under, or result in the creation or imposition of any lien, charge or encumbrance upon any property or assets of the Company or any of its subsidiaries pursuant to, or require the consent of any other party to, any Existing Instrument, except for such conflicts, breaches, Defaults, liens, charges or encumbrances as would not, individually or in the aggregate, result in a Material Adverse Change and (iii)&#160;will not result in any violation of any law, administrative regulation or administrative or court decree applicable to the Company or any subsidiary.&nbsp;&nbsp;Except for such consent, approval, authorization or other order of, or registration or filing with, the Exchange, no consent, approval, authorization or other order of, or registration or filing with, any court or other governmental or regulatory authority or agency, is required for the Company&#8217;s execution, delivery and performance of this Agreement and consummation of the transactions contemplated hereby and by the Prospectus, except such as have been obtained or made by the Company and are in full force and effect under the Securities Act, applicable state securities or blue sky laws and from the Financial Industry Regulatory Authority (&#8220;</font><font style="font-weight:bold;text-decoration:underline;color:#000000;">FINRA</font><font style="color:#000000;">&#8221;).&nbsp;&nbsp;</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(n)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">No Material Actions or Proceedings</font><font style="color:#000000;">.&nbsp;&nbsp;Except as disclosed in the Prospectus, there are no legal or governmental actions, suits or proceedings pending or, to the Company&#8217;s knowledge, threatened (i)&#160;against the Company or any of its subsidiaries, (ii)&#160;to the Company&#8217;s knowledge, which has as the subject thereof any officer or director of the Company and is required to be disclosed by the Company pursuant to the Exchange Act, (iii) which has as the subject thereof any property owned or leased by the Company or any of its subsidiaries or (iv)&#160;relating to environmental or discrimination matters, where in any such case (A)&#160;there is a reasonable possibility that such action, suit or proceeding might be determined adversely to the Company or such subsidiary and (B)&#160;any such action, suit or proceeding, if so determined adversely, would reasonably be expected to result in a Material Adverse Change or adversely affect the ability of the Company to consummate the transactions contemplated by this Agreement.&nbsp;&nbsp;No material labor dispute with the employees of the Company or any of its subsidiaries exists or, to the Company&#8217;s knowledge, is threatened or imminent.&nbsp;&nbsp;</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(o)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">All Necessary Permits, etc</font><font style="color:#000000;">.&nbsp;&nbsp;Except as otherwise disclosed in the Prospectus, the Company and each subsidiary possess or has obtained such valid and current certificates, authorizations or permits issued by the appropriate state, federal or foreign regulatory agencies or bodies necessary to conduct their respective businesses, other than those the failure to possess or own would not result in a Material Adverse Change, and neither the Company nor any subsidiary has received any written notice of proceedings relating to the revocation or modification of, or non-compliance with, any such certificate, authorization or permit which, singly or in the aggregate, if the subject of an unfavorable decision, ruling or finding, would result in a Material Adverse Change.&nbsp;&nbsp;</font></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT 10.1</p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU9"></a><font style="color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(p)&#160;</font><font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Tax Law Compliance</font><font style="color:#000000;">.&nbsp;&nbsp;Subject to any permitted extensions, the Company and its consolidated subsidiaries have filed all necessary federal, state and foreign income, property and franchise tax returns and have paid all taxes required to be paid by any of them and, if due and payable, any related or similar assessment, fine or penalty levied against any of them except as may be being contested in good faith and by appropriate proceedings.&nbsp;&nbsp;The Company has made adequate charges, accruals and reserves in the applicable financial statements referred to in Section&#160;1 (i) above in respect of all federal, state and foreign income, property and franchise taxes for all periods as to which the tax liability of the Company or any of its consolidated subsidiaries has not been finally determined.&nbsp;&nbsp;</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(q)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Insurance</font><font style="color:#000000;">.&nbsp;&nbsp;Except as otherwise described in the Prospectus, each of the Company and its subsidiaries are insured by insurers believed to be financially sound and reputable, with policies in such amounts and with such deductibles and covering such risks as are customary for the business for which it is engaged.&nbsp;&nbsp;The Company has no reason to believe that it or any subsidiary will not be able (i)&#160;to renew its existing insurance coverage as and when such policies expire or (ii)&#160;to obtain comparable coverage from similar institutions as may be necessary or appropriate to conduct its business as now conducted and at a cost that would not result in a Material Adverse Change.&nbsp;&nbsp;</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(r)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">No Price Stabilization or Manipulation</font><font style="color:#000000;">.&nbsp;&nbsp;The Company has not taken and will not take, directly or indirectly, any action designed to or that might be reasonably expected to cause or result in stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Common Stock.&nbsp;&nbsp;</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(s)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Related Party Transactions</font><font style="color:#000000;">.&nbsp;&nbsp;There are no business relationships or related-party transactions involving the Company or any subsidiary or any other person required to be described in the Prospectus which have not been described as required.</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(t)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Exchange Act Compliance</font><font style="color:#000000;">.&nbsp;&nbsp;The documents incorporated or deemed to be incorporated by reference in the Prospectus, at the time they were or hereafter are filed with the Commission, complied and will comply in all material respects with the requirements of the Exchange Act, and, when read together with the other information in the Prospectus, at each Applicable Time, will not contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading.&nbsp;&nbsp;</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(u)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">No Unlawful Contributions or Other Payments</font><font style="color:#000000;">.&nbsp;&nbsp;Neither the Company nor any of its subsidiaries nor, to the Company&#8217;s knowledge, any employee or agent of the Company or any subsidiary, has made any contribution or other payment to any official of, or candidate for, any federal, state or foreign office in violation of any law or of the character required to be disclosed in the Prospectus.&nbsp;&nbsp;</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU10"></a>(v)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Company&#8217;s Accounting System</font><font style="color:#000000;">.&nbsp;&nbsp;The Company maintains a system of accounting controls in a manner designed to provide reasonable assurance that (i)&#160;transactions are executed in accordance with management&#8217;s general or specific authorization; (ii)&#160;transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles in the United States and to maintain accountability for assets; (iii)&#160;access to </font></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT 10.1</p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="color:#000000;">assets is permitted only in accordance with management&#8217;s general or specific authorization; and (iv)&#160;the recorded accountability for assets is compared with existing assets at reasonable intervals and appropriate action is taken with respect to any differences. The Company has established and maintains disclosure controls and procedures (as such term is defined in Rule&#160;13a-15(e)&#160;and 15d-15(e)&#160;under the Exchange Act).</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(w)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Compliance with Environmental Laws</font><font style="color:#000000;">. Except as otherwise described in the Prospectus, and except as would not, individually or in the aggregate, result in a Material Adverse Change (i)&#160;neither the Company nor any of its subsidiaries is in violation of any federal, state, local or foreign law or regulation relating to pollution or protection of human health or the environment (including, without limitation, ambient air, surface water, groundwater, land surface or subsurface strata) or wildlife, including without limitation, laws and regulations relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants, wastes, toxic substances, hazardous substances, petroleum and petroleum products (collectively, &#8220;</font><font style="font-weight:bold;text-decoration:underline;color:#000000;">Materials of Environmental Concern</font><font style="color:#000000;">&#8221;), or otherwise relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Materials of Environment Concern (collectively, &#8220;</font><font style="font-weight:bold;text-decoration:underline;color:#000000;">Environmental Laws</font><font style="color:#000000;">&#8221;), which violation includes, but is not limited to, noncompliance with any permits or other governmental authorizations required for the operation of the business of the Company or its subsidiaries under applicable Environmental Laws, or noncompliance with the terms and conditions thereof, nor has the Company or any of its subsidiaries received any written communication, whether from a governmental authority, citizens group, employee or otherwise, that alleges that the Company or any of its subsidiaries is in violation of any Environmental Law; (ii)&#160;there is no claim, action or cause of action filed with a court or governmental authority, no investigation with respect to which the Company has received written notice, and no written notice by any person or entity alleging potential liability for investigatory costs, cleanup costs, governmental responses costs, natural resources damages, property damages, personal injuries, attorneys&#8217; fees or penalties arising out of, based on or resulting from the presence, or release into the environment, of any Material of Environmental Concern at any location owned, leased or operated by the Company or any of its subsidiaries, now or in the past (collectively, &#8220;</font><font style="font-weight:bold;text-decoration:underline;color:#000000;">Environmental Claims</font><font style="color:#000000;">&#8221;), pending or, to the Company&#8217;s knowledge, threatened in writing against the Company or any of its subsidiaries or any person or entity whose liability for any Environmental Claim the Company or any of its subsidiaries has retained or assumed either contractually or by operation of law; and (iii)&#160;to the Company&#8217;s knowledge, there are no past or present actions, activities, circumstances, conditions, events or incidents, including, without limitation, the release, emission, discharge, presence or disposal of any Material of Environmental Concern, that would reasonably be expected to result in a violation of any Environmental Law or an Environmental Claim against the Company or any of its subsidiaries or against any person or entity whose liability for any Environmental Claim the Company or any of its subsidiaries has retained or assumed either contractually or by operation of law.</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU11"></a>(x)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Intellectual Property.</font><font style="color:#000000;">&nbsp;&nbsp;Except as otherwise disclosed in the Prospectus, the Company and its subsidiaries own or possess the valid right to use all (i) patents, patent applications, trademarks, trademark registrations, service marks, service mark registrations, Internet domain name registrations, copyrights, copyright registrations, licenses, trade secret rights (&#8220;Intellectual Property Rights&#8221;) and (ii) inventions, software, works of authorships, trade names, databases, formulae, know how, Internet domain names and other intellectual property (including trade secrets and other unpatented and/or unpatentable proprietary confidential information, </font></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT 10.1</p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="color:#000000;">systems, or procedures), in each case reasonably necessary to conduct their respective businesses as now conducted, except for those rights as such failure to own, possess, license, or acquire such rights would not reasonably be expected to result in a Material Adverse Change (collectively, "Intellectual Property Assets").&nbsp;&nbsp;The Company and its subsidiaries have not received written notice of any challenge, which is, to their knowledge, still pending, by any other person to the rights of the Company and its subsidiaries with respect to any Intellectual Property Rights or Intellectual Property Assets owned or used by the Company or its subsidiaries.&nbsp;&nbsp;Except as would not reasonably be expected to result in a Material Adverse Change, to the knowledge of the Company, (i) the Company and its subsidiaries&#8217; respective businesses as now conducted do not give rise to any infringement of, any misappropriation of, or other violation of, any valid and enforceable Intellectual Property Rights of any other person, (ii) all licenses for the use of material Intellectual Property Rights described in the Prospectus are valid, binding upon, and enforceable by or against the parties thereto in accordance to its terms, (iii) the Company has complied in all material respects with, and is not in breach, nor has received any written asserted or threatened claim of breach, of any such Intellectual Property license, and the Company has no knowledge of any breach or anticipated breach by any other person to any Intellectual Property license.&nbsp;&nbsp;Except as described in the Prospectus, to the Company&#8217;s knowledge, no claim has been made against the Company alleging the infringement by the Company of any patent, trademark, service mark, trade name, copyright, trade secret, license in or other intellectual property right or franchise right of any person.&nbsp;&nbsp;The Company has taken all reasonable steps to protect, maintain and safeguard its Intellectual Property Rights, including the execution of appropriate nondisclosure and confidentiality agreements.&nbsp;&nbsp;The consummation of the transactions contemplated by this Agreement will not result in the loss or impairment of or payment of any additional amounts with respect to, nor require the consent of any other person in respect of, the Company's right to own, use, or hold for use any of the Intellectual Property Rights as owned, used or held for use in the conduct of the business as currently conducted. </font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(y)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Regulatory Authorizations</font><font style="color:#000000;">.&nbsp;&nbsp;Except as disclosed in the Prospectus, each of the Company and its subsidiaries possesses all certificates, authorizations and permits issued by the appropriate federal, state or foreign regulatory authorities necessary to conduct its business as currently conducted (including without limitation, those required for the manufacture and distribution of its product candidates for clinical and nonclinical testing, and the clinical and nonclinical testing of any product candidates) as disclosed in the Prospectus, except where the failure to possess such certificates, authorizations and permits would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Change.</font><font style="margin-left:36pt;color:#000000;"></font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(z)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Brokers</font><font style="color:#000000;">.&nbsp;&nbsp;There is no broker, finder or other party that is entitled to receive from the Company any brokerage or finder&#8217;s fee or other fee or commission as a result of any transactions contemplated by this Agreement, except as may otherwise exist with respect to the Agent pursuant to this Agreement. </font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(aa)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">No Outstanding Loans or Other Indebtedness</font><font style="color:#000000;">.&nbsp;&nbsp;Except as described in the Prospectus, there are no outstanding loans, advances (except normal advances for business expenses in the ordinary course of business) or guarantees or indebtedness by the Company to or for the benefit of any of the officers or directors of the Company or any of the members of any of them.</font></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT 10.1</p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU12"></a><font style="color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(bb)&#160;</font><font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">No Reliance</font><font style="color:#000000;">.&nbsp;&nbsp;The Company has not relied upon the Agent or legal counsel for the Agent for any legal, tax or accounting advice in connection with the offering and sale of the Placement Shares. </font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(cc)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Agent Purchases</font><font style="color:#000000;">.&nbsp;&nbsp;The Company acknowledges and agrees that the Agent has informed the Company that the Agent may, to the extent permitted under </font><font style="letter-spacing:-0.15pt;color:#000000;">the Securities Act</font><font style="color:#000000;"> and the Exchange Act, purchase and sell shares of </font><font style="letter-spacing:-0.15pt;color:#000000;">Common</font><font style="color:#000000;"> Stock outside of this Agreement for its own account while this Agreement is in effect.</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(dd)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Compliance with Certain Laws, Rules, Procedures, Etc</font><font style="color:#000000;">.&nbsp;&nbsp;Except as disclosed in the Prospectus, to the Company&#8217;s knowledge, the conduct of the preclinical and clinical testing,&nbsp;&nbsp;and manufacture of the products of the Company or any subsidiary is in compliance, in all material respects, with all laws, rules and regulations applicable to such activities, including without limitation applicable good laboratory practices, good clinical practices and good manufacturing practices, except for such non-compliance as would not, individually or in the aggregate, reasonably be expected to result in a Material Adverse Change. The descriptions of the results of such tests and trials contained in the Prospectus are accurate in all material respects. Except as otherwise disclosed in the Prospectus, the Company has not received notice of adverse finding, warning letter or clinical hold notice from the U.S. Food and Drug Administration (&#8220;</font><font style="font-weight:bold;text-decoration:underline;color:#000000;">FDA</font><font style="color:#000000;">&#8221;) or any non-U.S. counterpart, or any untitled letter or other correspondence or notice from the FDA or any other governmental authority or agency or any institutional or ethical review board alleging or asserting noncompliance with any law, rule or regulation applicable in any jurisdiction, except notices, letters, and correspondences and non-U.S. counterparts thereof alleging or asserting such noncompliance as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Change. Except as disclosed in the Prospectus, neither the Company nor any subsidiary has, either voluntarily or involuntarily, initiated, conducted or issued, or caused to be initiated, conducted or issued, any recall, field correction, market withdrawal or replacement, safety alert, warning, &#8220;dear doctor&#8221; letter, investigator notice, or other notice or action relating to an alleged or potential lack of safety or efficacy of any product of the Company or any subsidiary, any alleged product defect of any product of the Company or the subsidiary, or any violation of any material applicable law, rule, regulation or any clinical trial or marketing license, approval, permit or authorization for any product of the Company or any subsidiary, and the Company is not aware of any facts or information that would cause it to initiate any such notice or action and has no knowledge or reason to believe that the FDA, any non-U.S. counterpart,&nbsp;&nbsp;or any other governmental agency or authority or any institutional or ethical review board or other non-governmental authority intends to impose, require, request or suggest such notice or action, except in each case as would not, individually or in the aggregate, reasonably be expected to result in a Material Adverse Change. The Company has not received and is otherwise not aware of any notices, correspondence or other communication from the FDA or other governmental regulatory agency or subdivision thereof, or any institutional or ethical review boards, asserting non-compliance with any applicable statutes, rules, regulations, orders, or other laws, or requiring or requesting the termination, suspension or modification of any preclinical or clinical studies, tests, investigations, or trials conducted by, or on behalf of, the Company or any subsidiary or in which the Company or any subsidiary has participated.</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU13"></a>The Company acknowledges that the Agent and, for purposes of the opinions to be delivered pursuant to <font style="text-decoration:underline;">Section 7</font> hereof, counsel to the Company and counsel to the Agent, will rely </p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT 10.1</p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">upon the accuracy and truthfulness of the foregoing representations and hereby consents to such reliance.</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.&#160;&#160;<font style="margin-left:72pt;"></font><font style="text-decoration:underline;color:#000000;">Covenants of the Company</font><font style="color:#000000;">.&nbsp;&nbsp;The Company covenants and agrees with the Agent that:</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Registration Statement Amendments</font><font style="color:#000000;">.&nbsp;&nbsp;After the date of this Agreement and during any period in which a Prospectus relating to any Placement Shares is required to be delivered by the Agent under the Securities Act (including in circumstances where such requirement may be satisfied pursuant to Rule&#160;172 under the Securities Act), (i)&#160;the Company will notify the Agent promptly of the time when any subsequent amendment to the Registration Statement, other than documents incorporated by reference, has been filed with the Commission and/or has become effective or any subsequent supplement to the Prospectus has been filed and of any request by the Commission for any amendment or supplement to the Registration Statement or Prospectus (insofar as it relates to the transactions contemplated hereby) or for additional information, (ii) the Company will not file any amendment or supplement to the Registration Statement or Prospectus, other than documents incorporated by reference, relating to the Placement Shares or a security convertible into the Placement Shares unless a copy thereof has been submitted to the Agent within two days before the filing and the Agent has not reasonably objected thereto within the two day period (</font><font style="font-style:italic;color:#000000;">provided, however</font><font style="color:#000000;">, that (A) the failure of the Agent to make such objection shall not relieve the Company of any obligation or liability hereunder, or affect the Agent&#8217;s right to rely on the representations and warranties made by the Company in this Agreement and (B) the Company has no obligation to provide the Agent any advance copy of such filing or to provide the Agent an opportunity to object to such filing if such filing does not name the Agent or does not relate to the transactions contemplated hereunder; provided, further, that the only remedy the Agent shall have with respect to the failure by the Company to provide the Agent with such copy shall be to cease making sales under this Agreement) and the Company will furnish to the Agent at the time of filing thereof a copy of any document that upon filing is deemed to be incorporated by reference into the Registration Statement or Prospectus, except for those documents available via IDEA; and (iii) the Company will cause each amendment or supplement to the Prospectus, other than documents incorporated by reference, to be filed with the Commission as required pursuant to the applicable paragraph of Rule 424(b) of the Securities Act (the determination to file or not file any amendment or supplement with the Commission under this Section 7(a), based on the Company&#8217;s reasonable opinion or reasonable objections, shall be made exclusively by the Company). </font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Notice of Commission Stop Orders</font><font style="color:#000000;">.&nbsp;&nbsp;The Company will advise the Agent, promptly after it receives notice or obtains knowledge thereof, of the issuance or threatened issuance by the Commission of any stop order suspending the effectiveness of the Registration Statement, of the suspension of the qualification of the Placement Shares for offering or sale in any jurisdiction, or of the initiation or threatening of any proceeding for any such purpose; and it will promptly use its commercially reasonable efforts to prevent the issuance of any stop order or to obtain its withdrawal if such a stop order should be issued.</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU14"></a>(c)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Delivery of Prospectus; Subsequent Changes</font><font style="color:#000000;">.&nbsp;&nbsp;During any period in which a Prospectus relating to the Placement Shares is required to be delivered by the Agent under the Securities Act with respect to a pending sale of the Placement Shares, (including in circumstances where such requirement may be satisfied pursuant to Rule 172 under the Securities Act), the Company will comply in all material respects with all requirements imposed upon it by the </font></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT 10.1</p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="color:#000000;">Securities Act, as from time to time in force, and to file on or before their respective due dates (taking into account any extensions available under the Exchange Act) all reports and any definitive proxy or information statements required to be filed by the Company with the Commission pursuant to Sections 13(a), 13(c), 14, 15(d) or any other provision of or under the Exchange Act.&nbsp;&nbsp;If during such period any event occurs as a result of which the Prospectus as then amended or supplemented would include an untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances then existing, not misleading, or if during such period it is necessary to amend or supplement the Registration Statement or Prospectus to comply with the Securities Act, the Company will promptly notify the Agent to suspend the offering of Placement Shares during such period and the Company will promptly amend or supplement the Registration Statement or Prospectus (at the expense of the Company) so as to correct such statement or omission or effect such compliance; </font><font style="font-style:italic;color:#000000;">provided, however</font><font style="color:#000000;">, that the Company may delay any such amendment or supplement if, in the judgment of the Company, it is in the best interests of the Company to do so.</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Listing of Placement Shares</font><font style="color:#000000;">.&nbsp;&nbsp;During any period in which the Prospectus relating to the Placement Shares is required to be delivered by the Agent under the Securities Act with respect to a pending sale of the Placement Shares (including in circumstances where such requirement may be satisfied pursuant to Rule 172 under the Securities Act), the Company will use its commercially reasonable efforts to cause the Placement Shares to be listed on the Exchange and to qualify the Placement Shares for sale under the securities laws of such jurisdictions as the Agent reasonably designates and to continue such qualifications in effect so long as required for the distribution of the Placement Shares; </font><font style="font-style:italic;color:#000000;">provided, however,</font><font style="color:#000000;"> that the Company shall not be required in connection therewith to qualify as a foreign corporation or dealer in securities or file a general consent to service of process in any jurisdiction.</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(e)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Delivery of Registration Statement and Prospectus</font><font style="color:#000000;">.&nbsp;&nbsp;The Company will furnish to the Agent and its counsel (at the expense of the Company) copies of the Registration Statement, the Prospectus (including all documents incorporated by reference therein) and all amendments and supplements to the Registration Statement or Prospectus that are filed with the Commission during any period in which a Prospectus relating to the Placement Shares is required to be delivered under the Securities Act (including all documents filed with the Commission during such period that are deemed to be incorporated by reference therein), in each case as soon as reasonably practicable and in such quantities as the Agent may from time to time reasonably request and, at the Agent&#8217;s request, will also furnish copies of the Prospectus to each exchange or market on which sales of the Placement Shares may be made; </font><font style="font-style:italic;color:#000000;">provided, however,</font><font style="color:#000000;"> that the Company shall not be required to furnish any document (other than the Prospectus) to the Agent to the extent such document is available on IDEA.&nbsp;&nbsp;</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(f)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Earnings Statement</font><font style="color:#000000;">.&nbsp;&nbsp;The Company will make generally available to its security holders as soon as practicable, but in any event not later than 15 months after the end of the Company&#8217;s current fiscal quarter, an earnings statement covering a 12-month period that satisfies the provisions of Section 11(a) and Rule 158 of the Securities Act.&nbsp;&nbsp;For the avoidance of doubt, the Company&#8217;s compliance with the reporting requirements of the Exchange Act shall be deemed to satisfy this Section 7(f).</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU15"></a>(g)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Expenses</font><font style="color:#000000;">.&nbsp;&nbsp;The Company, whether or not the transactions contemplated hereunder are consummated or this Agreement is terminated, in accordance with the provisions of Section </font></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT 10.1</p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="color:#000000;">11 hereunder, will pay the following expenses all incident to the performance of its obligations hereunder, including, but not limited to, expenses relating to (i) the preparation, printing and filing of the Registration Statement and each amendment and supplement thereto, of each Prospectus and of each amendment and supplement thereto, (ii) the preparation, issuance and delivery of the Placement Shares, (iii) the qualification of the Placement Shares under securities laws in accordance with the provisions of </font><font style="text-decoration:underline;color:#000000;">Section 7(d)</font><font style="color:#000000;"> of this Agreement, including filing fees (provided, however, that any fees or disbursements of counsel for the Agent in connection therewith shall be paid by the Agent except as set forth in (vii) below), (iv) the printing and delivery to the Agent of copies of the Prospectus and any amendments or supplements thereto, and of this Agreement, (v) the fees and expenses incurred in connection with the listing or qualification of the Placement Shares for trading on the Exchange, (vi) filing fees and expenses, if any, of the Commission and the FINRA Corporate Financing Department and (vii) the reasonable fees and disbursements of the Agent&#8217;s counsel, in an aggregate amount not to exceed $30,000.&nbsp;&nbsp;</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(h)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Use of Proceeds</font><font style="color:#000000;">.&nbsp;&nbsp;The Company will use the Net Proceeds as described in the Prospectus in the section entitled &#8220;Use of Proceeds.&#8221;</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(i)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Notice of Other Sales</font><font style="color:#000000;">.&nbsp;&nbsp;During the pendency of any Placement Notice given hereunder, and for 3 trading days following the termination of any Placement Notice given hereunder, the Company shall provide the Agent notice as promptly as reasonably possible before it offers to sell, contracts to sell, sells, grants any option to sell or otherwise disposes of any shares of Common Stock (other than Placement Shares offered pursuant to the provisions of this Agreement) or securities convertible into or exchangeable for Common Stock, warrants or any rights to purchase or acquire Common Stock; </font><font style="font-style:italic;color:#000000;">provided</font><font style="color:#000000;">, that such notice shall not be required in connection with the (i) issuance, grant or sale of Common Stock, options to purchase shares of Common Stock or Common Stock issuable upon the exercise of options or other equity awards pursuant to any stock incentive plan or other stock plan or arrangement described in the Prospectus or pursuant to any qualifying employment inducement award under the Exchange rules, (ii) the issuance of securities in connection with an acquisition, merger or sale or purchase of assets or (iii) the issuance or sale of Common Stock pursuant to any dividend reinvestment plan that the Company may adopt from time to time provided the implementation of such is disclosed to the Agent in advance, (iv) any shares of common stock issuable upon the exchange, conversion or redemption of securities or the exercise of warrants, options or other rights in effect or outstanding or (v) filing of any registration statement under the Securities Act, or any pre-effective or post-effective amendment or prospectus supplement thereto, other than the Registration Statement, relating to the Placement Shares or that is intended to commence a public offering of equity, equity-linked or other derivative securities of the Company.</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(j)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Change of Circumstances</font><font style="color:#000000;">.&nbsp;&nbsp;The Company will, at any time during a fiscal quarter in which the Company intends to tender a Placement Notice or sell Placement Shares, advise the Agent promptly after it shall have received notice or obtained knowledge thereof, of any information or fact that would alter or affect in any material respect any opinion, certificate, letter or other document required to be provided to the Agent pursuant to this Agreement.</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU16"></a>(k)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Due Diligence Cooperation</font><font style="color:#000000;">.&nbsp;&nbsp;The Company will cooperate with any reasonable due diligence review conducted by the Agent or its agents in connection with the transactions contemplated hereby, including, without limitation, providing information and making available </font></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT 10.1</p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="color:#000000;">documents and senior corporate officers, during regular business hours and at the Company&#8217;s principal offices, as the Agent may reasonably request.</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(l)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Required Filings Relating to Placement of Placement Shares</font><font style="color:#000000;">.&nbsp;&nbsp;The Company agrees that on such dates as the Securities Act shall require, the Company will (i)&#160;file a prospectus supplement with the Commission under the applicable paragraph of Rule 424(b) under the Securities Act (each and every filing under Rule 424(b), a &#8220;</font><font style="font-weight:bold;text-decoration:underline;color:#000000;">Filing Date</font><font style="color:#000000;">&#8221;), which prospectus supplement will set forth, within the relevant period, the amount of Placement Shares sold through the Agent, the Net Proceeds to the Company and the compensation payable by the Company to the Agent with respect to such Placement Shares (provided that the Company may satisfy its obligations under this Section 7(l)(i) by effecting a filing in accordance with the Exchange Act with respect to such information), and (ii) deliver such number of copies of each such prospectus supplement to each exchange or market on which such sales were effected as may be required by the rules or regulations of such exchange or market.</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(m)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Representation Dates; Certificate</font><font style="color:#000000;">.&nbsp;&nbsp;On or prior to the date of the first Placement Notice hereunder and each time the Company (i) amends or supplements the Registration Statement or the Prospectus relating to the Placement Shares (other than a prospectus supplement filed in accordance with Section 7(l) of this Agreement) by means of a post-effective amendment, sticker, or supplement but not by means of incorporation of document(s) by reference to the Registration Statement or the Prospectus relating to the Placement Shares; (ii) files an annual report on Form 10-K under the Exchange Act; (iii) files its quarterly reports on Form 10-Q under the Exchange Act; or (iv) files a current report on Form 8-K containing amended financial information (other than information &#8220;furnished&#8221; pursuant to Items 2.02 or 7.01 of Form 8-K) under the Exchange Act (each date of filing of one or more of the documents referred to in clauses (i) through (iv) shall be a </font><font style="font-weight:bold;color:#000000;">"</font><font style="font-weight:bold;text-decoration:underline;color:#000000;">Representation Date</font><font style="font-weight:bold;color:#000000;">"</font><font style="color:#000000;">); the Company shall furnish the Agent with a certificate, in the form attached hereto as </font><font style="text-decoration:underline;color:#000000;">Exhibit 7(m)</font><font style="color:#000000;"> within three (3) Trading Days of any Representation Date.&nbsp;&nbsp;The requirement to provide a certificate under this Section 7(m) shall be waived for any Representation Date occurring at a time at which no Placement Notice is pending, which waiver shall continue until the earlier to occur of the date the Company delivers a Placement Notice hereunder (which for such calendar quarter shall be considered a Representation Date) and the next occurring Representation Date; </font><font style="font-style:italic;color:#000000;">provided</font><font style="color:#000000;">, </font><font style="font-style:italic;color:#000000;">however</font><font style="color:#000000;">, that such waiver shall not apply for any Representation Date on which the Company files its annual report on Form 10-K.&nbsp;&nbsp;Notwithstanding the foregoing, if the Company subsequently decides to sell Placement Shares following a Representation Date when the Company relied on such waiver and did not provide the Agent with a certificate under this </font><font style="text-decoration:underline;color:#000000;">Section 7(m)</font><font style="color:#000000;">, then before the Company delivers the Placement Notice or the Agent sells any Placement Shares, the Company shall provide the Agent with a certificate, in the form attached hereto as </font><font style="text-decoration:underline;color:#000000;">Exhibit 7(m)</font><font style="color:#000000;">, dated the date of the Placement Notice.</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="OLE_LINK12"></a><a name="OLE_LINK11"></a><a name="_AEIOULastRenderedPageBreakAEIOU17"></a>(n)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Legal Opinion</font><font style="color:#000000;"><a name="OLE_LINK12"></a><a name="OLE_LINK11"></a>.&nbsp;&nbsp;On or prior to the date of the first Placement Notice hereunder and within three (3) Trading Days of each Representation Date with respect to which the Company is obligated to deliver a certificate in the form attached hereto as </font><font style="text-decoration:underline;color:#000000;">Exhibit 7(m)</font><font style="color:#000000;"> for which no waiver is applicable, the Company shall cause to be furnished to the Agent a written opinion and 10b-5 statement of Latham &amp; Watkins LLP (&#8220;</font><font style="font-weight:bold;text-decoration:underline;color:#000000;">Company Counsel</font><font style="color:#000000;">&#8221;), or other counsel satisfactory to the Agent, in form and substance satisfactory to the Agent and its counsel, dated the date that the opinion is required to be delivered, substantially similar to the form of opinion and 10b-5 statement provided to the Agent, modified, as necessary, to relate to the Registration Statement and the </font></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT 10.1</p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="color:#000000;">Prospectus as then amended or supplemented; </font><font style="font-style:italic;color:#000000;">provided</font><font style="color:#000000;">, </font><font style="font-style:italic;color:#000000;">however</font><font style="color:#000000;">, that in lieu of such opinion and 10b-5 statement for subsequent Representation Dates, Company Counsel may furnish the Agent with a letter (a &#8220;</font><font style="font-weight:bold;text-decoration:underline;color:#000000;">Reliance Letter</font><font style="color:#000000;">&#8221;) to the effect that the Agent may rely on a prior opinion and 10b-5 statement delivered under this </font><font style="text-decoration:underline;color:#000000;">Section 7(n)</font><font style="color:#000000;"> to the same extent as if it were dated the date of such letter (except that statements in such prior opinion and 10b-5 statement shall be deemed to relate to the Registration Statement and the Prospectus as amended or supplemented at such Representation Date).&nbsp;&nbsp;</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(o)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Comfort Letter</font><font style="color:#000000;">.&nbsp;&nbsp;On or prior to the date of the first Placement Notice hereunder and within five (5) Trading Days of each Representation Date with respect to which the Company is obligated to deliver a certificate in the form attached hereto as </font><font style="text-decoration:underline;color:#000000;">Exhibit 7(m)</font><font style="color:#000000;"> for which no waiver is applicable (other than pursuant to Section 7(m)(iii)), the Company shall cause its independent accountants to furnish the Agent letters (the </font><font style="font-weight:bold;color:#000000;">"</font><font style="font-weight:bold;text-decoration:underline;color:#000000;">Comfort Letters</font><font style="font-weight:bold;color:#000000;">"</font><font style="color:#000000;">), dated the date of the Comfort Letter is delivered, in form and substance satisfactory to the Agent, (i) confirming that they are an independent registered public accounting firm within the meaning of the Securities Act and the PCAOB, (ii) stating, as of such date, the conclusions and findings of such firm with respect to the financial information and other matters ordinarily covered by accountants&#8217; &#8220;comfort letters&#8221; to the Agent in connection with registered public offerings (the first such letter, the </font><font style="font-weight:bold;color:#000000;">&#8220;</font><font style="font-weight:bold;text-decoration:underline;color:#000000;">Initial Comfort Letter</font><font style="font-weight:bold;color:#000000;">&#8221;</font><font style="color:#000000;">) and (iii) updating the Initial Comfort Letter with any information that would have been included in the Initial Comfort Letter had it been given on such date and modified as necessary to relate to the Registration Statement and the Prospectus, as amended and supplemented to the date of such letter.</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(p)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Market Activities</font><font style="color:#000000;">.&nbsp;&nbsp;The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares or (ii) sell, bid for, or purchase the Placement Shares, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the Agent; provided, however, that the Company may bid for and purchase shares of its common stock in accordance with Rule 10b-18 under the Exchange Act.</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(q)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Insurance</font><font style="color:#000000;">.&nbsp;&nbsp;The Company and its subsidiaries shall maintain, or caused to be maintained, insurance in such amounts and covering such risks as are generally deemed prudent and customary for the business for which it is engaged.</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(r)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Compliance with Laws</font><font style="color:#000000;">.&nbsp;&nbsp;The Company and its subsidiaries shall maintain, or cause to be maintained, all material environmental permits or other governmental&nbsp;&nbsp;authorizations necessary to conduct their businesses as described in the Prospectus, and the Company and its subsidiaries shall conduct their businesses, or cause their businesses to be conducted, in substantial compliance with such permits and other governmental authorizations and under applicable environmental laws, except where the failure to maintain or be in compliance with such permits and other governmental authorizations would not reasonably be expected to have a Material Adverse Change.</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU18"></a>(s)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Investment Company Act</font><font style="color:#000000;">.&nbsp;&nbsp;The Company will conduct its affairs in such a manner so as to reasonably ensure that neither it nor the subsidiaries will be or become, at any time prior to the termination of this Agreement, an &#8220;investment company,&#8221; as such term is defined in the </font></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT 10.1</p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="color:#000000;">Investment Company Act of 1940, as amended, assuming no change in the Commission&#8217;s current interpretation as to entities that are not considered an investment company.</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(t)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Securities Act and Exchange Act</font><font style="color:#000000;">.&nbsp;&nbsp;The Company will use its commercially reasonable efforts to comply in all material respects with all requirements imposed upon it by the Securities Act and the Exchange Act as from time to time in force, so far as necessary to permit the continuance of sales of, or dealings in, the Placement Shares as contemplated by the provisions hereof and the Prospectus.</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(u)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">No Offer to Sell</font><font style="color:#000000;">.&nbsp;&nbsp;Other than a free writing prospectus (as defined in Rule 405 under the Act) approved in advance by the Company and the Agent in its capacity as principal or agent hereunder, neither the Agent nor the Company (including its agents and representatives, other than the Agent in its capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Common Stock relating to the Placement Shares to be sold by the Agent as principal or agent hereunder</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(v)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Sarbanes-Oxley Act</font><font style="color:#000000;">.&nbsp;&nbsp;The Company and its subsidiaries will use their commercially reasonable efforts to comply in all material respects with all effective applicable provisions of the Sarbanes-Oxley Act.</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.&#160;&#160;<font style="margin-left:72pt;"></font><font style="text-decoration:underline;color:#000000;">Conditions to the Agent&#8217;s Obligations</font><font style="color:#000000;">. The obligations of the Agent hereunder with respect to a Placement will be subject to the continuing accuracy and completeness of the representations and warranties made by the Company herein, to the due performance by the Company of its obligations hereunder, to the completion by the Agent of a due diligence review satisfactory to the Agent in its reasonable judgment, and to the continuing satisfaction (or waiver by the Agent in its sole discretion) of the following additional conditions:</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Registration Statement Effective</font><font style="color:#000000;">.&nbsp;&nbsp;The Registration Statement shall be effective and shall be available for (i) all sales of Placement Shares issued pursuant to all prior Placement Notices and (ii) the sale of all Placement Shares contemplated to be issued by any Placement Notice.</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU19"></a>(b)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">No Material Notices</font><font style="color:#000000;">.&nbsp;&nbsp;None of the following events shall have occurred and be continuing:&nbsp;&nbsp;(i) receipt by the Company or any of its subsidiaries of any request for additional information from the Commission or any other federal or state governmental authority during the period of effectiveness of the Registration Statement, the response to which would require any post-effective amendments or supplements to the Registration Statement or the Prospectus; (ii)&#160;the issuance by the Commission or any other federal or state governmental authority of any stop order suspending the effectiveness of the Registration Statement or the initiation of any proceedings for that purpose; (iii) receipt by the Company of any notification with respect to the suspension of the qualification or exemption from qualification of any of the Placement Shares for sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose; (iv) the occurrence of any event that makes any material statement made in the Registration Statement or the Prospectus or any material document incorporated or deemed to be incorporated therein by reference untrue in any material respect or that requires the making of any changes in the Registration Statement, related Prospectus or such documents so that, in the case of the Registration Statement, it will not contain any materially untrue statement of a material fact or </font></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT 10.1</p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="color:#000000;">omit to state any material fact required to be stated therein necessary to make the statements therein not misleading and, that in the case of the Prospectus, it will not contain any materially untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading. </font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">No Misstatement or Material Omission</font><font style="color:#000000;">.&nbsp;&nbsp;The Agent shall not have advised the Company that the Registration Statement or Prospectus, or any amendment or supplement thereto, contains an untrue statement of fact that in the Agent&#8217;s reasonable opinion is material, or omits to state a fact that in the Agent&#8217;s opinion is material and is required to be stated therein or is necessary to make the statements therein not misleading.</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Material Changes</font><font style="color:#000000;">.&nbsp;&nbsp;Except as contemplated in the Prospectus, or disclosed in the Company&#8217;s reports filed with the Commission, there shall not have been any material adverse change, on a consolidated basis, in the authorized capital stock of the Company or any Material Adverse Change or any development that would reasonably be expected to result in a Material Adverse Change, or any downgrading in or withdrawal of the rating assigned to any of the Company&#8217;s securities (other than asset backed securities) by any rating organization or a public announcement by any rating organization that it has under surveillance or review its rating of any of the Company&#8217;s securities (other than asset backed securities), the effect of which, in the case of any such action by a rating organization described above, in the reasonable judgment of the Agent (without relieving the Company of any obligation or liability it may otherwise have), is so material as to make it impracticable or inadvisable to proceed with the offering of the Placement Shares on the terms and in the manner contemplated in the Prospectus.</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(e)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Company Counsel Legal Opinion</font><font style="color:#000000;">.&nbsp;&nbsp;The Agent shall have received the opinion and 10b-5 statement of Company Counsel or Reliance Letter required to be delivered pursuant </font><font style="text-decoration:underline;color:#000000;">Section 7(n)</font><font style="color:#000000;"> on or before the date on which such delivery of such opinion and 10b-5 statement or Reliance Letter is required pursuant to </font><font style="text-decoration:underline;color:#000000;">Section 7(n)</font><font style="color:#000000;">.</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(f)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Agent Counsel Legal Opinion</font><font style="color:#000000;">.&nbsp;&nbsp;The Agent shall have received from Duane Morris LLP, counsel for the Agent, such opinion or opinions, on or before the date on which the delivery of the Company Counsel legal opinion and 10b-5 statement are required pursuant to </font><font style="text-decoration:underline;color:#000000;">Section 7(n)</font><font style="color:#000000;">, with respect to such matters as the Agent may reasonably require, and the Company shall have furnished to such counsel such documents as they request for enabling them to pass upon such matters.</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(g)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Comfort Letter</font><font style="color:#000000;">.&nbsp;&nbsp;The Agent shall have received the Comfort Letter required to be delivered pursuant </font><font style="text-decoration:underline;color:#000000;">Section 7(o)</font><font style="color:#000000;"> on or before the date on which such delivery of such opinion is required pursuant to </font><font style="text-decoration:underline;color:#000000;">Section 7(o)</font><font style="color:#000000;">.</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(h)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Representation Certificate</font><font style="color:#000000;">.&nbsp;&nbsp;The Agent shall have received the certificate required to be delivered pursuant to </font><font style="text-decoration:underline;color:#000000;">Section&#160;7(m)</font><font style="color:#000000;"> on or before the date on which delivery of such certificate is required pursuant to </font><font style="text-decoration:underline;color:#000000;">Section 7(m)</font><font style="color:#000000;">.</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(i)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">No Suspension</font><font style="color:#000000;">.&nbsp;&nbsp;Trading in the Common Stock shall not have been suspended on the Exchange.</font></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT 10.1</p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU20"></a><font style="color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(j)&#160;</font><font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Other Materials</font><font style="color:#000000;">.&nbsp;&nbsp;On each date on which the Company is required to deliver a certificate pursuant to </font><font style="text-decoration:underline;color:#000000;">Section 7(m)</font><font style="color:#000000;">, the Company shall have furnished to the Agent such appropriate further information, certificates and documents as the Agent may have reasonably requested. All such opinions, certificates, letters and other documents shall have been in compliance with the provisions hereof. The Company will furnish the Agent with such conformed copies of such opinions, certificates, letters and other documents as the Agent shall have reasonably requested.</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(k)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Securities Act Filings Made</font><font style="color:#000000;">.&nbsp;&nbsp;All filings with the Commission required by Rule 424 under the Securities Act to have been filed prior to the issuance of any Placement Notice hereunder shall have been made within the applicable time period prescribed for such filing by Rule 424.</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(l)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Approval for Listing</font><font style="color:#000000;">.&nbsp;&nbsp;The Placement Shares shall either have been (i) approved for listing on the Exchange, subject only to notice of issuance, or (ii) the Company shall have filed an application for listing of the Placement Shares on the Exchange at, or prior to, the issuance of any Placement Notice.</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(m)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">No Termination Event</font><font style="color:#000000;">.&nbsp;&nbsp;There shall not have occurred any event that would permit the Agent to terminate this Agreement pursuant to </font><font style="text-decoration:underline;color:#000000;">Section 11(a)</font><font style="color:#000000;">.</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.&#160;&#160;<font style="margin-left:72pt;"></font><font style="text-decoration:underline;color:#000000;">Indemnification and Contribution</font><font style="color:#000000;">.</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Company Indemnification</font><font style="color:#000000;">.&nbsp;&nbsp;The Company agrees to indemnify and hold harmless the Agent, the directors, officers, partners, employees and agents of the Agent and each person, if any, who (i) controls the Agent within the meaning of Section 15 of </font><font style="letter-spacing:-0.15pt;color:#000000;">the Securities Act</font><font style="color:#000000;"> or Section 20 of the Exchange Act, or (ii) is controlled by or is under common control with the Agent (an &#8220;</font><font style="font-weight:bold;text-decoration:underline;color:#000000;">Agent Affiliate</font><font style="color:#000000;">&#8221;) from and against any and all losses, claims, liabilities, expenses and damages (including, but not limited to, any and all reasonable investigative, legal and other expenses&nbsp;&nbsp;incurred in connection with, and any and all amounts paid in settlement (in accordance with </font><font style="text-decoration:underline;color:#000000;">Section 9(c)</font><font style="color:#000000;">) of, any action, suit or proceeding between any of the indemnified parties and any indemnifying parties or between any indemnified party and any third party, or otherwise, or any claim asserted), as and when incurred, to which the Agent, or any such person, may become subject under </font><font style="letter-spacing:-0.15pt;color:#000000;">the </font><font style="color:#000000;">Securities Act, the Exchange Act or other federal or state statutory law or regulation, at common law or otherwise, insofar as such losses, claims, liabilities, expenses or damages arise out of or are based, directly or indirectly, on (x) any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement or the Prospectus or any amendment or supplement to the Registration Statement or the Prospectus or in any free writing prospectus or (y) the omission or alleged omission to state in any such document a material fact required to be stated in it or necessary to make the statements in it not misleading; </font><font style="font-style:italic;color:#000000;">provided</font><font style="color:#000000;">, </font><font style="font-style:italic;color:#000000;">however</font><font style="color:#000000;">, that this indemnity agreement shall not apply to the extent that such loss, claim, liability, expense or damage arises from the sale of the Placement Shares pursuant to this Agreement and is caused directly or indirectly by an untrue statement or omission made in reliance upon and in conformity with written information relating to the Agent and furnished to the Company by the Agent expressly for inclusion in any document as described in clause (x) of this Section 9</font><font style="text-decoration:underline;color:#000000;">(a)</font><font style="color:#000000;">. This indemnity agreement will be in addition to any liability that the Company might otherwise have.</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU21"></a>(b)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Agent Indemnification</font><font style="color:#000000;">. The Agent agrees to indemnify and hold harmless the Company and its directors and each officer of the Company that signed the Registration Statement, </font></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT 10.1</p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="color:#000000;">and each person, if any, who (i)&#160;controls the Company within the meaning of Section 15 of </font><font style="letter-spacing:-0.15pt;color:#000000;">the Securities Act</font><font style="color:#000000;"> or Section 20 of the Exchange Act or (ii) is controlled by or is under common control with the Company (a &#8220;</font><font style="font-weight:bold;text-decoration:underline;color:#000000;">Company Affiliate</font><font style="color:#000000;">&#8221;) against any and all loss, liability, claim, damage and expense described in the indemnity contained in </font><font style="text-decoration:underline;color:#000000;">Section 9(a)</font><font style="color:#000000;">, as incurred, but only with respect to untrue statements or omissions, or alleged untrue statements or omissions, made in the Registration Statement (or any amendments thereto) or the Prospectus (or any amendment or supplement thereto) or any free writing prospectus in reliance upon and in conformity with written information relating to the Agent and furnished to the Company by the Agent expressly for inclusion in any document as described in clause (x) of </font><font style="text-decoration:underline;color:#000000;">Section 9(a)</font><font style="color:#000000;">.</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU22"></a>(c)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Procedure</font><font style="color:#000000;">.&nbsp;&nbsp;Any party that proposes to assert the right to be indemnified under this </font><font style="text-decoration:underline;color:#000000;">Section 9 </font><font style="color:#000000;">will, promptly after receipt of notice of commencement of any action against such party in respect of which a claim is to be made against an indemnifying party or parties under this </font><font style="text-decoration:underline;color:#000000;">Section 9</font><font style="color:#000000;">, notify each such indemnifying party in writing of the commencement of such action, enclosing a copy of all papers served, but the omission so to notify such indemnifying party will not relieve the indemnifying party from (i) any liability that it might have to any indemnified party otherwise than under this </font><font style="text-decoration:underline;color:#000000;">Section 9</font><font style="color:#000000;"> and (ii) any liability that it may have to any indemnified party under the foregoing provision of this </font><font style="text-decoration:underline;color:#000000;">Section 9</font><font style="color:#000000;"> unless, and only to the extent that, such omission results in the forfeiture of substantive rights or defenses by the indemnifying party. If any such action is brought against any indemnified party and it notifies the indemnifying party of its commencement, the indemnifying party will be entitled to participate in and, to the extent that it elects by delivering written notice to the indemnified party promptly after receiving notice of the commencement of the action from the indemnified party, jointly with any other indemnifying party similarly notified, to assume the defense of the action, with counsel reasonably satisfactory to the indemnified party, and after notice from the indemnifying party to the indemnified party of its election to assume the defense, the indemnifying party will not be liable to the indemnified party for any legal or other expenses except as provided below and except for the reasonable costs of investigation subsequently incurred by the indemnified party in connection with the defense. The indemnified party will have the right to employ its own counsel in any such action, but the fees, expenses and other charges of such counsel will be at the expense of such indemnified party unless (1) the employment of counsel by the indemnified party has been authorized in writing by the indemnifying party, (2) the indemnified party has reasonably concluded (based on advice of counsel) that there may be legal defenses available to it or other indemnified parties that are different from or in addition to those available to the indemnifying party, (3) a conflict or potential conflict exists (based on advice of counsel to the indemnified party) between the indemnified party and the indemnifying party (in which case the indemnifying party will not have the right to direct the defense of such action on behalf of the indemnified party) or (4) the indemnifying party has not in fact employed counsel to assume the defense of such action within a reasonable time after receiving notice of the commencement of the action, in each of which cases the reasonable fees, disbursements and other charges of counsel will be at the expense of the indemnifying party or parties. It is understood that the indemnifying party or parties shall not, in connection with any proceeding or related proceedings in the same jurisdiction, be liable for the reasonable fees, disbursements and other charges of more than one separate firm admitted to practice in such jurisdiction at any one time for all such indemnified party or parties. All such fees, disbursements and other charges will be reimbursed by the indemnifying party promptly as they are incurred. An indemnifying party will not, in any event, be liable for any settlement of any action or claim effected without its written consent.&nbsp;&nbsp;No indemnifying party shall, without the prior written consent </font></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT 10.1</p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="color:#000000;">of each indemnified party, settle or compromise or consent to the entry of any judgment in any pending or threatened claim, action or proceeding relating to the matters contemplated by this </font><font style="text-decoration:underline;color:#000000;">Section 9</font><font style="color:#000000;"> (whether or not any indemnified party is a party thereto), unless such settlement, compromise or consent includes an unconditional release of each indemnified party from all liability arising or that may arise out of such claim, action or proceeding. </font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU23"></a>(d)&#160;<font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Contribution</font><font style="color:#000000;">.&nbsp;&nbsp;In order to provide for just and equitable contribution in circumstances in which the indemnification provided for in the foregoing paragraphs of this </font><font style="text-decoration:underline;color:#000000;">Section 9</font><font style="color:#000000;"> is applicable in accordance with its terms but for any reason is held to be unavailable from the Company or the Agent, the Company and the Agent will contribute to the total losses, claims, liabilities, expenses and damages (including any investigative, legal and other expenses reasonably incurred in connection with, and any amount paid in settlement of, any action, suit or proceeding or any claim asserted, but after deducting any contribution received by the Company from persons other than the Agent, such as persons who control the Company within the meaning of </font><font style="letter-spacing:-0.15pt;color:#000000;">the Securities Act</font><font style="color:#000000;">, officers of the Company who signed the Registration Statement and directors of the Company, who also may be liable for contribution) to which the Company and the Agent may be subject in such proportion as shall be appropriate to reflect the relative benefits received by the Company on the one hand and the Agent on the other. The relative benefits received by the Company on the one hand and the Agent on the other hand shall be deemed to be in the same proportion as the total Net Proceeds from the sale of the Placement Shares (before deducting expenses) received by the Company bear to the total compensation received by the Agent from the sale of Placement Shares on behalf of the Company.&nbsp;&nbsp;If, but only if, the allocation provided by the foregoing sentence is not permitted by applicable law, the allocation of contribution shall be made in such proportion as is appropriate to reflect not only the relative benefits referred to in the foregoing sentence but also the relative fault of the Company, on the one hand, and the Agent, on the other, with respect to the statements or omission that resulted in such loss, claim, liability, expense or damage, or action in respect thereof, as well as any other relevant equitable considerations with respect to such offering. Such relative fault shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact relates to information supplied by the Company or the Agent, the intent of the parties and their relative knowledge, access to information and opportunity to correct or prevent such statement or omission. The Company and the Agent agree that it would not be just and equitable if contributions pursuant to this </font><font style="text-decoration:underline;color:#000000;">Section 9(d)</font><font style="color:#000000;"> were to be determined by pro rata allocation or by any other method of allocation that does not take into account the equitable considerations referred to herein. The amount paid or payable by an indemnified party as a result of the loss, claim, liability, expense, or damage, or action in respect thereof, referred to above in this </font><font style="text-decoration:underline;color:#000000;">Section 9(d)</font><font style="color:#000000;"> shall be deemed to include, for the purpose of this </font><font style="text-decoration:underline;color:#000000;">Section 9(d)</font><font style="color:#000000;">, any legal or other expenses reasonably incurred by such indemnified party in connection with investigating or defending any such action or claim to the extent consistent with </font><font style="text-decoration:underline;color:#000000;">Section 9(c)</font><font style="color:#000000;"> hereof.&nbsp;&nbsp;Notwithstanding the foregoing provisions of this </font><font style="text-decoration:underline;color:#000000;">Section 9(d)</font><font style="color:#000000;">, the Agent shall not be required to contribute any amount in excess of the commissions received by it under this Agreement and no person found guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of </font><font style="letter-spacing:-0.15pt;color:#000000;">the Securities Act</font><font style="color:#000000;">) will be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. For purposes of this </font><font style="text-decoration:underline;color:#000000;">Section 9(d)</font><font style="color:#000000;">, any person who controls a party to this Agreement within the meaning of </font><font style="letter-spacing:-0.15pt;color:#000000;">the Securities Act</font><font style="color:#000000;">, and any officers, directors, partners, employees or agents of the Agent, will have the same rights to contribution as that party, and each officer of the Company who signed the Registration Statement will have the </font></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT 10.1</p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="color:#000000;">same rights to contribution as the Company, subject in each case to the provisions hereof. Any party entitled to contribution, promptly after receipt of notice of commencement of any action against such party in respect of which a claim for contribution may be made under this </font><font style="text-decoration:underline;color:#000000;">Section 9(d)</font><font style="color:#000000;">, will notify any such party or parties from whom contribution may be sought, but the omission to so notify will not relieve that party or parties from whom contribution may be sought from any other obligation it or they may have under this </font><font style="text-decoration:underline;color:#000000;">Section 9(d)</font><font style="color:#000000;"> except to the extent that the failure to so notify such other party materially prejudiced the substantive rights or defenses of the party from whom contribution is sought. Except for a settlement entered into pursuant to the last sentence of </font><font style="text-decoration:underline;color:#000000;">Section 9(c)</font><font style="color:#000000;"> hereof, no party will be liable for contribution with respect to any action or claim settled without its written consent if such consent is required pursuant to </font><font style="text-decoration:underline;color:#000000;">Section 9(c)</font><font style="color:#000000;"> hereof.</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.&#160;&#160;<font style="margin-left:72pt;"></font><font style="text-decoration:underline;color:#000000;">Representations and Agreements to Survive Delivery</font><font style="color:#000000;">.&nbsp;&nbsp;The indemnity and contribution agreements contained in </font><font style="text-decoration:underline;color:#000000;">Section 9</font><font style="color:#000000;"> of this Agreement and all representations and warranties of the Company herein or in certificates delivered pursuant hereto shall survive, as of their respective dates, regardless of (i) any investigation made by or on behalf of the Agent, any controlling persons, or the Company (or any of their respective officers, directors or controlling persons), (ii) delivery and acceptance of the Placement Shares and payment therefor or (iii) any termination of this Agreement.</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11.&#160;&#160;<font style="margin-left:72pt;"></font><font style="text-decoration:underline;color:#000000;">Termination.</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)&#160;<font style="margin-left:36pt;color:#000000;">The Agent shall have the right by giving written notice as hereinafter specified at any time to terminate this Agreement if (i) any Material Adverse Change, or any development that would reasonably be expected to result in a Material Adverse Change has occurred that, in the reasonable judgment of the Agent, would materially impair the ability of the Agent to sell the Placement Shares hereunder, (ii) the Company shall have failed, refused or been unable to perform any agreement on its part to be performed hereunder; </font><font style="font-style:italic;color:#000000;">provided, however,</font><font style="color:#000000;"> in the case of any failure of the Company to deliver (or cause another person to deliver) any certification, opinion, or letter required under </font><font style="text-decoration:underline;color:#000000;">Sections</font><font style="color:#000000;"> </font><font style="text-decoration:underline;color:#000000;">7(m)</font><font style="color:#000000;">, </font><font style="text-decoration:underline;color:#000000;">7(n)</font><font style="color:#000000;">, or </font><font style="text-decoration:underline;color:#000000;">7(o)</font><font style="color:#000000;">, the Agent&#8217;s right to terminate shall not arise unless such failure to deliver (or cause to be delivered) continues for more than thirty (30) days from the date such delivery was required; or (iii)&#160;any other condition of the Agent&#8217;s obligations hereunder is not fulfilled, or (iv), any suspension or limitation of trading in the Placement Shares or in securities generally on the Exchange shall have occurred.&nbsp;&nbsp;Any such termination shall be without liability of any party to any other party except that the provisions of </font><font style="text-decoration:underline;color:#000000;">Section 7(g)</font><font style="color:#000000;"> (Expenses), </font><font style="text-decoration:underline;color:#000000;">Section 9</font><font style="color:#000000;"> (Indemnification and Contribution), </font><font style="text-decoration:underline;color:#000000;">Section 10</font><font style="color:#000000;"> (Representations and Agreements to Survive Delivery), </font><font style="text-decoration:underline;color:#000000;">Section 16</font><font style="color:#000000;"> (Applicable Law; Consent to Jurisdiction) and </font><font style="text-decoration:underline;color:#000000;">Section 17</font><font style="color:#000000;"> (Waiver of Jury Trial) hereof shall remain in full force and effect notwithstanding such termination. If the Agent elects to terminate this Agreement as provided in this </font><font style="text-decoration:underline;color:#000000;">Section 11(a)</font><font style="color:#000000;">, the Agent shall provide the required notice as specified in </font><font style="text-decoration:underline;color:#000000;">Section 12</font><font style="color:#000000;"> (Notices).</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)&#160;<font style="margin-left:36pt;color:#000000;">The Company shall have the right, by giving ten (10) days notice as hereinafter specified to terminate this Agreement in its sole discretion at any time after the date of this Agreement.&nbsp;&nbsp;Any such termination shall be without liability of any party to any other party except that the provisions of </font><font style="text-decoration:underline;color:#000000;">Section 7(g)</font><font style="color:#000000;">, </font><font style="text-decoration:underline;color:#000000;">Section 9</font><font style="color:#000000;">, </font><font style="text-decoration:underline;color:#000000;">Section 10</font><font style="color:#000000;">, </font><font style="text-decoration:underline;color:#000000;">Section 16</font><font style="color:#000000;"> and </font><font style="text-decoration:underline;color:#000000;">Section 17</font><font style="color:#000000;"> hereof shall remain in full force and effect notwithstanding such termination.</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU24"></a>(c)&#160;<font style="margin-left:36pt;color:#000000;">The Agent shall have the right, by giving ten (10) days notice as hereinafter specified to terminate this Agreement in its sole discretion at any time after the date of this </font></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT 10.1</p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="color:#000000;">Agreement.&nbsp;&nbsp;Any such termination shall be without liability of any party to any other party except that the provisions of </font><font style="text-decoration:underline;color:#000000;">Section 7(g)</font><font style="color:#000000;">, </font><font style="text-decoration:underline;color:#000000;">Section 9</font><font style="color:#000000;">, </font><font style="text-decoration:underline;color:#000000;">Section 10</font><font style="color:#000000;">, </font><font style="text-decoration:underline;color:#000000;">Section 16</font><font style="color:#000000;"> and </font><font style="text-decoration:underline;color:#000000;">Section 17</font><font style="color:#000000;"> hereof shall remain in full force and effect notwithstanding such termination.</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d)&#160;<font style="margin-left:36pt;color:#000000;">Unless earlier terminated pursuant to this </font><font style="text-decoration:underline;color:#000000;">Section 11</font><font style="color:#000000;">, this Agreement shall automatically terminate upon the issuance and sale of all of the Placement Shares through the Agent on the terms and subject to the conditions set forth herein; </font><font style="font-style:italic;color:#000000;">provided</font><font style="color:#000000;"> that the provisions of </font><font style="text-decoration:underline;color:#000000;">Section 7(g)</font><font style="color:#000000;">, </font><font style="text-decoration:underline;color:#000000;">Section 9</font><font style="color:#000000;">, </font><font style="text-decoration:underline;color:#000000;">Section 10</font><font style="color:#000000;">, </font><font style="text-decoration:underline;color:#000000;">Section 16</font><font style="color:#000000;"> and </font><font style="text-decoration:underline;color:#000000;">Section 17</font><font style="color:#000000;"> hereof shall remain in full force and effect notwithstanding such termination.</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(e)&#160;<font style="margin-left:36pt;color:#000000;">This Agreement shall remain in full force and effect unless terminated pursuant to </font><font style="text-decoration:underline;color:#000000;">Sections 11(a)</font><font style="color:#000000;">, </font><font style="text-decoration:underline;color:#000000;">(b)</font><font style="color:#000000;">, </font><font style="text-decoration:underline;color:#000000;">(c), or (d)</font><font style="color:#000000;"> above or otherwise by mutual agreement of the parties; </font><font style="font-style:italic;color:#000000;">provided, however, </font><font style="color:#000000;">that any such termination by mutual agreement shall in all cases be deemed to provide that </font><font style="text-decoration:underline;color:#000000;">Section 7(g)</font><font style="color:#000000;">, </font><font style="text-decoration:underline;color:#000000;">Section 9</font><font style="color:#000000;">, </font><font style="text-decoration:underline;color:#000000;">Section 10</font><font style="color:#000000;">, </font><font style="text-decoration:underline;color:#000000;">Section 16</font><font style="color:#000000;"> and </font><font style="text-decoration:underline;color:#000000;">Section 17</font><font style="color:#000000;"> shall remain in full force and effect.</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(f)&#160;<font style="margin-left:36pt;color:#000000;">Any termination of this Agreement shall be effective on the date specified in such notice of termination; </font><font style="font-style:italic;color:#000000;">provided, however,</font><font style="color:#000000;"> that such termination shall not be effective until the close of business on the date of receipt of such notice by the Agent or the Company, as the case may be. If such termination shall occur prior to the Settlement Date for any sale of Placement Shares, such Placement Shares shall settle in accordance with the provisions of this Agreement.</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(g)&#160;<font style="color:#000000;">Subject to the additional limitations set forth in </font><font style="text-decoration:underline;color:#000000;">Section 7</font><font style="color:#000000;"> of the Agreement, in the event of termination of this Agreement prior to the sale of any Placement Shares, the Agent shall be entitled only to reimbursement of its out-of-pocket expenses actually incurred. </font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12.&#160;&#160;<font style="margin-left:72pt;"></font><font style="text-decoration:underline;color:#000000;">Notices</font><font style="color:#000000;">.&nbsp;&nbsp;All notices or other communications </font><font style="letter-spacing:-0.15pt;color:#000000;">required or permitted to be given by any party to any other party pursuant to the terms of this Agreement </font><font style="color:#000000;">shall be in writing, unless otherwise specified in this Agreement, and if sent to the Agent, shall be delivered to the Agent at B. Riley FBR, Inc., 299 Park Avenue, 7th Floor, New York, NY 10171, Attention: General Counsel, Telephone:&nbsp;&nbsp; (212) 457-9947, Email: atmdesk@brileyfbr.com, with a copy to Duane Morris LLP , 1540 Broadway, New York, NY 10036, Attention: James T. Seery, Telephone: (973) 424-2088, Email: jtseery@duanemorris.com; or if sent to the Company, shall be delivered to Cytori Therapeutics, Inc., 3020 Callan Road, San Diego, CA 92121, Attention: Chief Executive Officer, with a copy to Latham &amp; Watkins LLP, 12670 High Bluff Drive, San Diego, CA 92130, Attention:</font><font style="margin-left:72pt;color:#000000;">Cheston J. Larson, Esq., Telephone: (858) 523-5435, Email: Cheston.Larson@lw.com.&nbsp;&nbsp;Each party to this Agreement may change such address for notices by sending to the parties to this Agreement written notice of a new address for such purpose.</font><font style="letter-spacing:-0.15pt;color:#000000;">&nbsp;&nbsp;Each such notice or other communication shall be deemed given (i) when delivered personally or by verifiable facsimile transmission (with an original to follow) on or before 4:30 p.m., New York City time, on a Business Day (as defined below), or, if such day is not a Business Day on the next succeeding Business Day, (ii) on the next Business Day after timely delivery to a nationally-recognized overnight courier and (iii) on the Business</font><font style="font-weight:bold;letter-spacing:-0.15pt;color:#000000;"> </font><font style="letter-spacing:-0.15pt;color:#000000;">Day actually received if deposited in the U.S. mail (certified or registered mail, return receipt requested, postage prepaid). For purposes of this Agreement, &#8220;</font><font style="font-weight:bold;text-decoration:underline;letter-spacing:-0.15pt;color:#000000;">Business Day</font><font style="letter-spacing:-0.15pt;color:#000000;">&#8221; shall mean any day on which the Exchange and commercial banks in the City of New York are open for business.</font></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT 10.1</p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU25"></a><font style="color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13.&#160;&#160;</font><font style="margin-left:72pt;"></font><font style="text-decoration:underline;color:#000000;">Successors and Assigns</font><font style="color:#000000;">.&nbsp;&nbsp;This Agreement shall inure to the benefit of and be binding upon the Company and the Agent and their respective successors and the affiliates, controlling persons, officers and directors referred to in </font><font style="text-decoration:underline;color:#000000;">Section 9</font><font style="color:#000000;"> hereof. References to any of the parties contained in this Agreement shall be deemed to include the successors and permitted assigns of such party. </font><font style="letter-spacing:-0.15pt;color:#000000;">Nothing in this Agreement, express or implied, is intended to confer upon any party other than the parties hereto or their respective successors and permitted assigns any rights, remedies, obligations or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement. Neither party may assign its rights or obligations under this Agreement without the prior written consent of the other party; </font><font style="font-style:italic;letter-spacing:-0.15pt;color:#000000;">provided</font><font style="letter-spacing:-0.15pt;color:#000000;">, </font><font style="font-style:italic;letter-spacing:-0.15pt;color:#000000;">however</font><font style="letter-spacing:-0.15pt;color:#000000;">, that the Agent may assign its rights and obligations hereunder to an affiliate of the Agent without obtaining the Company&#8217;s consent.</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14.&#160;&#160;<font style="margin-left:72pt;"></font><font style="text-decoration:underline;color:#000000;">Adjustments for Share Splits</font><font style="color:#000000;">.&nbsp;&nbsp;The parties acknowledge and agree that all share-related numbers contained in this Agreement shall be adjusted to take into account any share split, share dividend or similar event effected with respect to the Common Stock.</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15.&#160;&#160;<font style="margin-left:72pt;"></font><font style="text-decoration:underline;color:#000000;">Entire Agreement; Amendment; Severability</font><font style="color:#000000;">.&nbsp;&nbsp;This Agreement (including all schedules and exhibits attached hereto and Placement Notices issued pursuant hereto) constitutes the entire agreement and supersedes all other prior and contemporaneous agreements and undertakings, both written and oral, among the parties hereto with regard to the subject matter hereof.</font><font style="letter-spacing:-0.15pt;color:#000000;"> Neither this Agreement nor any term hereof may be amended except pursuant to a written instrument executed by the Company and the Agent.&nbsp;&nbsp;In the event that any one or more of the provisions contained herein, or the application thereof in any circumstance, is held invalid, illegal or unenforceable as written </font><font style="color:#000000;">by a court of competent jurisdiction</font><font style="letter-spacing:-0.15pt;color:#000000;">, </font><font style="color:#000000;">then such provision shall be given full force and effect to the fullest possible extent that it is</font><font style="letter-spacing:-0.15pt;color:#000000;"> valid, legal and enforceable,</font><font style="color:#000000;"> and the remainder of the terms and provisions herein shall be construed as if such </font><font style="letter-spacing:-0.15pt;color:#000000;">invalid, illegal or unenforceable </font><font style="color:#000000;">term or provision was not contained herein, but only to the extent that giving effect to such provision and the remainder of the terms and provisions hereof shall be in accordance with the intent of the parties as reflected in this Agreement</font><font style="letter-spacing:-0.15pt;color:#000000;">.</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16.&#160;&#160;<font style="margin-left:72pt;"></font><font style="text-decoration:underline;color:#000000;">Applicable Law; Consent to Jurisdiction</font><font style="color:#000000;">. This Agreement shall be governed by, and construed in accordance with, the internal laws of the State of New York without regard to the principles of conflicts of laws. </font><font style="letter-spacing:-0.15pt;color:#000000;">Each party hereby irrevocably submits to the non-exclusive jurisdiction of the state and federal courts sitting in the City of New York, borough of Manhattan, for the adjudication of any dispute hereunder or in connection with any transaction contemplated hereby, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue of such suit, action or proceeding is improper.&nbsp;&nbsp;Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof (certified or registered mail, return receipt requested) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof.&nbsp;&nbsp;Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law.</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.&#160;&#160;<font style="margin-left:72pt;"></font><font style="text-decoration:underline;color:#000000;">Waiver of Jury Trial</font><font style="color:#000000;">.&nbsp;&nbsp;The Company and the Agent each hereby irrevocably waives any right it may have to a trial by jury in respect of any claim based upon or arising out of this Agreement or any transaction contemplated hereby.</font></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT 10.1</p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU26"></a><font style="color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18.&#160;&#160;</font><font style="margin-left:72pt;"></font><font style="text-decoration:underline;color:#000000;">Absence of Fiduciary Relationship</font><font style="font-style:italic;color:#000000;">.&nbsp;&nbsp;</font><font style="color:#000000;">The Company acknowledges and agrees that:</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)&#160;<font style="margin-left:36pt;color:#000000;">the Agent has been retained solely to act as sales agent in connection with the sale of the </font><font style="color:#000000;">Common Stock and that no fiduciary, advisory or agency relationship between the Company and the Agent has been created in respect of any of the transactions contemplated by this Agreement, irrespective of whether the Agent has advised or is advising the Company on other matters;</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)&#160;<font style="margin-left:36pt;color:#000000;">the Company is capable of evaluating and understanding and understands and accepts the terms, risks and conditions of the transactions contemplated by this Agreement;</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)&#160;<font style="margin-left:36pt;color:#000000;">the Company has been advised that the Agent and its affiliates are engaged in a broad range of transactions which may involve interests that differ from those of the Company and that the Agent has no obligation to disclose such interests and transactions to the Company by virtue of any fiduciary, advisory or agency relationship; and</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d)&#160;<font style="margin-left:36pt;color:#000000;">the Company waives, to the fullest extent permitted by law, any claims it may have against the Agent, for breach of fiduciary duty or alleged breach of fiduciary duty and agrees that the Agent shall have no liability (whether direct or indirect) to the Company in respect of such a fiduciary claim or to any person asserting a fiduciary duty claim on behalf of or in right of the Company, including stockholders, partners, employees or creditors of the Company.</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19.&#160;&#160;<font style="margin-left:72pt;"></font><font style="text-decoration:underline;color:#000000;">Counterparts</font><font style="color:#000000;">.&nbsp;&nbsp;This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Delivery of an executed Agreement by one party to the other may be made by facsimile or electronic transmission.</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20.&#160;&#160;<font style="margin-left:72pt;"></font><font style="text-decoration:underline;color:#000000;">Definitions</font><font style="color:#000000;">. As used in this Agreement, the following term has the meaning set forth below:</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)&#160;<font style="margin-left:36pt;color:#000000;">&#8220;</font><font style="font-style:italic;color:#000000;">Applicable Time</font><font style="color:#000000;">&#8221; means the date of this Agreement, each Representation Date, the date on which a Placement Notice is given, and any date on which Placement Shares are sold hereunder.</font></p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT 10.1</p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.59%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU27"></a><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If the foregoing correctly sets forth the understanding between the Company and the Agent, please so indicate in the space provided below for that purpose, whereupon this letter shall constitute a binding agreement between the Company and the Agent.&nbsp;&nbsp;</font></p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:45.57%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Very truly yours,</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:45.57%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:45.57%;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">B.RILEY FBR, INC.</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:45.57%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:45.57%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:&#160;&nbsp;&nbsp;&nbsp;&nbsp; <font style="text-decoration:underline;">/s/ Patrice McNicoll</font><font style="text-decoration:underline;margin-left:36pt;"></font></p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:45.57%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.59%;">Name:<font style="margin-left:36pt;"></font>Patrice McNicoll</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:45.57%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.59%;">Title:&nbsp;&nbsp;<font style="margin-left:36pt;"></font>Co-Head of Investment Banking</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:45.57%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:45.57%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:45.57%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:45.57%;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">ACCEPTED as of the date</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:45.57%;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">first-above written:</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:45.57%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:45.57%;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">CYTORI THERAPEUTICS, INC.</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:45.57%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:45.57%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:&nbsp;&nbsp;<font style="text-decoration:underline;">/s/ Tiago Gir&#227;o </font><font style="text-decoration:underline;margin-left:36pt;"></font></p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:45.57%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name:<font style="margin-left:36pt;"></font>Tiago Gir&#227;o</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:45.57%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title:<font style="margin-left:36pt;">VP of Finance and Chief Financial Officer</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT 10.1</p>
<p style="text-align:right;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU28"></a><font style="text-decoration:underline;">SCHEDULE 1</font></p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;text-transform:uppercase;font-size:12pt;font-family:Times New Roman;font-style:normal;font-variant: normal;"><font style="text-decoration:underline;">form of PLACEMENT NOTICE</font></p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:15.38%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">From:</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">[&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;]</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:15.38%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cc:</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">[&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;]</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:15.38%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To: </font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">[ ]</p></td></tr></table></div>
<p style="text-align:left;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Subject: <font style="margin-left:36pt;">the Agent at the Market Offering&#8212;Placement Notice</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Ladies and Gentlemen:</p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the terms and subject to the conditions contained in the Sales Agreement between Cytori Therapeutics, Inc. (the &#8220;<font style="text-decoration:underline;">Company</font>&#8221;), and b. Riley FBR, Inc. (the &#8220;<font style="text-decoration:underline;">Agent</font>&#8221;) dated&nbsp;&nbsp;June&nbsp;&nbsp;, 2018 (the &#8220;<font style="text-decoration:underline;">Agreement</font>&#8221;), I hereby request on behalf of the Company that the Agent sell up to [ ] shares of the Company&#8217;s common stock, par value 0.001 per share, at a minimum market price of $_______ per share.&nbsp;&nbsp;Sales should begin on the date of this Notice and shall continue until [DATE] [all shares are sold].</p>
<p style="text-align:right;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT 10.1</p>
<p style="text-align:right;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU29"></a><font style="text-decoration:underline;">SCHEDULE 2</font></p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">The Company</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Marc H. Hedrick<font style="margin-left:36pt;">Chief Executive Officer and President</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tiago Gir&#227;o<font style="margin-left:36pt;">Chief Financial Officer</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">The Agent</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Matthew Feinberg<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">mfeinberg@brileyfbr.com</font>&nbsp;&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Ryan Loforte<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">rloforte@brileyfbr.com</font> </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Patrice McNicoll<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">pmcnicoll@brileyfbr.com </font> </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Keith Pompliano<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">kpompliano@brileyfbr.com</font> </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">with a copy to <font style="text-decoration:underline;">atmdesk@brileyfbr.com</font> </p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT 10.1</p>
<p style="text-align:right;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU30"></a><font style="text-decoration:underline;">SCHEDULE 3</font></p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Compensation</font></p>
<p style="text-align:left;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Agent shall be paid compensation, or allowed a discount, in an amount equal to 3.0% of the gross proceeds from the sales of Common Stock pursuant to the terms of this Agreement.</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Exhibit 7(m) </font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">OFFICER CERTIFICATE</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The undersigned, the duly qualified and elected _______________________, of Cytori Therapeutics, Inc.<font style="font-weight:bold;"> </font>(&#8220;<font style="font-weight:bold;text-decoration:underline;">Company</font>&#8221;), a Delaware corporation, does hereby certify in such capacity and on behalf of the Company, pursuant to <font style="text-decoration:underline;">Section 7(m)</font> of the Sales Agreement dated June&nbsp;&nbsp;, 2018 (the &#8220;<font style="font-weight:bold;text-decoration:underline;">Sales Agreement</font>&#8221;) between the Company and B. Riley FBR, Inc., that to the knowledge of the undersigned.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(i)<font style="margin-left:36pt;">The representations and warranties of the Company in </font><font style="text-decoration:underline;">Section 6</font> of the Sales Agreement (A) to the extent such representations and warranties are subject to qualifications and exceptions contained therein relating to materiality or Material Adverse Change, are true and correct on and as of the date hereof with the same force and effect as if expressly made on and as of the date hereof, except for those representations and warranties that speak solely as of a specific date and which were true and correct as of such date, and (B) to the extent such representations and warranties are not subject to any qualifications or exceptions, are true and correct in all material respects as of the date hereof as if made on and as of the date hereof with the same force and effect as if expressly made on and as of the date hereof except for those representations and warranties that speak solely as of a specific date and which were true and correct as of such date; and</p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(ii)<font style="margin-left:36pt;">The Company has complied with all agreements and satisfied all conditions on its part to be performed or satisfied pursuant to the Sales Agreement at or prior to the date hereof.</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Sales Agreement.</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:46.15%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">CYTORI THERAPEUTICS, INC.</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:46.15%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:46.15%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:46.15%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:<font style="text-decoration:underline;margin-left:36pt;"></font></p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:50%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name:</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:50%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date:<font style="text-decoration:underline;margin-left:36pt;"></font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-top:12pt;text-align:justify;margin-bottom:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g201806011825106681022.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g201806011825106681022.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "Q"FD# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#DX/V@O&\(
MB#G39]CAF,EL1O CV;3M8<%OGXP=W0A?EJ-_C]XY:)4%Q8HRQ",N+499@KJ7
M.3C<2RL<#;F-< #<&\OHH ]4?]H+QN]P95.FHA<,(EMCM RGR\L3@[&'7/[U
M^>$V_5=? %??] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 5\P:M^T'XL;5I?L"Z5':12L(Q'"[B5!(I!+/ACE5*YVIP[' .W;Z
M_P#&G6_[$^%^J;+CR;B^VV47R;M^\_.O0@9C$G)Q['.*^0* /4/^%_>.?LOE
M?:+'?_SV^RC?_JMGKM^]^\Z?>X^Y\E2/^T%XW>X,JG340N&$2VQV@93Y>6)P
M=C#KG]Z_/";?*Z* /4)/C]XY??MN+&/=NQMM1\F?,QC)/3>N,Y_U29SE]_TW
MX;UN'Q'X:TW68/+"7ENDI1)!((V(^9-PZE6RIX'(/ KX4KZ3_9U\4-?>'[[P
MW<21[].<36H+J&,4A)8!<9(5^2V3_K0.,"@#VRBBB@ HHHH **** "BBB@ H
MHHH \ ^(_P 8O%/A3XCZAI.G"Q:QM/)VQ30%M^8=QW$$'DR \$?ZM/\ :W<>
MGQ^\<K$R&XL79HC&'-J,JQ5%#C!QN!5F&1MS(V01M"Y_QM_Y*]KO_;O_ .B(
MZ\_H ]4?]H+QN]P95.FHA<,(EMCM RGR\L3@[&'7/[U^>$VC_M!>-V1U!TU2
MR2J&%L<J7;*L,MC*#A<Y!'W@QYKRNB@#U"3X_>.7W[;BQCW;L;;4?)GS,8R3
MTWKC.?\ 5)G.7WR/^T%XW>X,JG340N&$2VQV@93Y>6)P=C#KG]Z_/";?*Z*
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M).-I,:E<J3O^CZ^+/B=$L7Q-\1*EO) #>NVQXF0DGDMAF8X8G<#G!!! 4$*
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M44 %%%% !1110 4444 %%%% !1110 4444 ? %%%% !7W_7P!7W_ $ %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%5[^^M],TZYO[R3
MR[6UB::9]I.U%!+' Y. #TH ^;/VBM?74/&-CHL31LFEVY:3",&667#%23P1
ML6(C']X\]AXW6IXDUN;Q'XEU+69_,#WEP\H1Y#(8U)^5-QZA5PHX' ' K+H
M**** "NX^$GB=/"OQ%T^ZN9_)L;G-I=,=N C]"Q;&U0X1B<C 4]>AX>I()YK
M6XBN+>62&>)P\<D;%61@<@@CD$'O0!]]T5S?@#7V\4> ]&U>5I&GGMPL[NBJ
M7E0E)&PO !96(QC@C@=*Z2@ HHHH **** "BBB@ HHHH ^0/C;_R5[7?^W?_
M -$1UY_7V?K?PM\&^(]8GU;5M&^T7T^WS)?M4R;MJA1PK@#@ <"L_P#X4E\/
M/^A>_P#)VX_^.4 ?(%%?7_\ PI+X>?\ 0O?^3MQ_\<H_X4E\//\ H7O_ "=N
M/_CE 'R!17U__P *2^'G_0O?^3MQ_P#'*/\ A27P\_Z%[_R=N/\ XY0!\@45
M).(5N)5MY))( Y$;R($9ESP2H) ..V3CU-1T %%%>R? WP)X;\86^MRZ]:QW
MKV[PK%$)IHVB!#Y8[2 0V !R2-AX&1D \;HKZ_\ ^%)?#S_H7O\ R=N/_CE'
M_"DOAY_T+W_D[<?_ !R@#Y HKZ__ .%)?#S_ *%[_P G;C_XY1_PI+X>?]"]
M_P"3MQ_\<H ^0*^L_@,DR?"NS:59 CW$S1%B2"N\CY?G; W!N@3G/RG[[W/^
M%)?#S_H7O_)VX_\ CE=9H'AS2/"VEKINBV,=I:!R^Q26+,>I9F)+'H,DG@ =
M * -2BBB@ HHHH *\[^.,C)\)-7589)!(\"LRE<1CSD.YLD'&0!QDY8<8R1Z
M)7G?QQ$Q^$FKF*2-4#P&4,A8LOG)PIR-IW;3D@\ C'.0 ?(E%%% !7VG\,7F
MD^&7AUIS(7%DB@N"#M'"]43C:!C@\8^9_OM\65]I_#&)HOAEX=5[>. FR1MB
M1*@(/(;"LPRP.XG.2220I)4 '64444 %%%% !1110 4444 %?%'Q'2W3XE>(
MQ:OOC_M"8D[BWSEB7&2J]&W#&..@+#YC]KU\4?$>5)OB5XC:-MRC4)E)\A8N
M0Q!&U3@X((W=6^\<$F@#EZ*** /</V:X\^(=<D\O.VT1=^S.,OTW;#C..F]<
MX^Z^,I]'U\Z?LTVK/K.OW82,I%;Q1%CMW LS$ ?*3CY#G# <#*MP4^BZ "BB
MB@ HHHH **** "BBB@ HHHH ***X?XM^)Y/"OPZU"ZMI_)OKG%I:L-V0[]2I
M7&U@@=@<C!4=>A /ESQ_KZ^*/'FLZO$T;03W!6!T1E#Q( D;8;D$JJDYQR3P
M.E<W110 4444 %>^?LV:^PN-9\.2-(49!?0*$7:I!"29/7)S%@<CY3T[^!UT
M'@;69?#_ (YT74XGV>3=H)#E!F-CM<9<A1E&89) &<Y&,@ ^WZ*** "BBB@
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MH ]DHHHH **** "OF#XU_$W_ (2/43X?T.^\S1+?'VAXAA;J8$_Q9^:->,=
M6R?F 4UW?QM^)\WANW7P[H-W&FJ7"$W<T;'S+2,@8 [!V!/.<J!G'S*P^9*
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M** "BBB@ KR?]H:;ROAK&GVF>+S=0B39$,K-\KMM?D87C=T/S*O'<>L5Y/\
MM#/(OPUC"7GD*^H1!X\L/M VN=G P<$!_FP/DZYP" ?+%%%% !1110 5]$?L
M^>.DELV\&7IVS0^9/8N64!D)R\0'!+ EG'7(+= HS\[U<TG4IM&UFQU2W6-I
M[*XCN(UD!*ED8, <$'&1ZB@#[SHK#\(^*+'QAX:M-8L)(R)4 FB5]Q@EP-T;
M< Y!/7 R,$<$5N4 %%%% !1110 5\\?M+^5_:/AW'G^=Y4^[=O\ +VY3&W/R
M;L[LX^;&W=QMKZ'KY\_:8,WVCPTK1QB )<E'#DL6S%N!7&  -N#DYR>!CD \
M#HHHH [3X2VK7GQ4\/Q(D;%;@RX?;C"(SD_,K#("Y' .<89#AA]EU\8?"OR/
M^%H>'OM'W/M8Q_JOO8.W_6?+]['3YO[GS[:^SZ "BBB@ HHHH **** "L?Q/
MXGTOPCH<VKZO/Y5O'PJKR\KGHB#NQQ^A)( )&Q7RY\>O&DVM^+#X=@>/^S])
M?!,4Q833,HW%@. 4Y0#J#OYYP #S_P 7>*+[QAXEN]8OY)"97(AB9]P@BR=L
M:\ 8 /7 R<D\DUAT44 %%%>N?#GX(7WBFWM]8UV62PT>9&:*.,XN)A@;6 *D
M*AR3DY) X&&#4 >1UJ6'AK7M53?IVB:E>(4#[K>U>0;2S*#\H/!9'&?56'8U
M]EZ-X&\+>'X$BTS0;&#;C$AB#R'#B09D;+'#JK#)X*KCH,=!0!\0?\()XP_Z
M%37/_!=-_P#$UEW6DZE8HSW>GW=NB/L9I860!MSK@Y'7='(,>J,/X37WG10!
M\ 45]SZMX4\/Z]%+'JFBV-UYNXL\D"E\LJH6#XW*VU$&X$'Y5YX%</XB^ W@
M[6O,EL8I](NF\Q@UH^8R[<@F-L@*#_"A3@D>F #8^#]NEM\*- CCE\Q3$\A;
M*\%I'8CY68<$D=<\<A3E1W%9^A:9_8GA[3-)\[SOL-I%;>;MV[]B!=V,G&<9
MQDUH4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110!\ 4444 %??]? %??] !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !7F?QS\4-X>^'TUI;R1B[U9_L8!==PB()
ME8*0=PV_(>F/,!R#C/IE?+'Q^\3IK7CF/2[:?S+728O*8#:5$[',F&')P BD
M'HR,,=<@'D]%%% &YX.T!O%/C'2M%59"EU<*LOELJLL0^:1@6XR$#'OTZ'I6
M7?V-QIFHW-A>1^7=6LK0S)N!VNI(89'!P0>E>L?L[:)]N\<W>K26^^'3;0[)
M=^/+FD.U>,\Y02CH0/KBN?\ C3HG]B?%#5-EOY-O?;;V+Y]V_>/G;J2,R"3@
MX]AC% 'G]%%% 'T)^S9KZFWUGPY(T8=7%] H1MS @))D],#$6!P?F/7M[W7Q
M1\//$\GA+QSIFJ>?Y-J)1%>$[BI@8X?*KRV!\P'/S*IP<5]KT %%%% !1110
M 4444 %%%% !1110 4444 %%%% 'P1?MOU&Y;S8)=TK'S+>/RXWY/*+M7:I[
M#:,#C Z57JQ?RI/J-S+$V^-Y696\A8<@DD'RT)5/]U3@=!Q5>@ KZ(_9H;_B
M7>(E\V XE@/EK'B1<A^6;;RIQP-QP58X&[+?.]?1'[-#?\2[Q$OFP'$L!\M8
M\2+D/RS;>5..!N."K' W98 ]WHHHH **** "BBB@ HHHH **** "O-_CKYO_
M  JC4O+\_;YL'F>5LV[?,7[^[G;G'W/FW;?X=U>D5YW\<9X8?A)JZ2RQH\SP
M)$K, 7;SD;"^IVJQP.P)[4 ?(E%%% !7V?\ "M$3X7^'A&\#K]D!)@967)))
M!*JHW Y##&0V02QRQ^,*^S_A7)YGPO\ #S>9YF+0+G?OZ$C&=[],8QD8QC:F
M-B@'84444 %%%% !1110 4444 %?%'Q';=\2O$9\V"7_ (F$PW01[%&&(P1M
M7YAT8XY8$Y;.X_:]?%'Q'E2;XE>(VC;<HU"92?(6+D,01M4X.""-W5OO'!)H
M Y>BBB@#W3]FFU9]9U^["1E(K>*(L=NX%F8@#Y2<?(<X8#@95N"GT77SI^S3
MM_MG7\VL;/\ 9XL7!1MT8W-E =N &X)!8$[!@-@E?HN@ HHHH **** "BBB@
M HHHH **** "OG#]HSQ/<3ZY9>&(IX&L;>)+N9$P7$YW@!CVPA! X^_DY^7'
MT7//#:V\MQ<2QPP1(7DDD8*J*!DDD\  =Z^(/&.NS>)?&.JZO-+'(;BX8HT>
M=OECY4 RJD@*%&2H)QDC.: ,.BBB@#<T?0&U+P[XBUAED\C2K>%@ZLH'FR3H
MBJP/)!7S3QW49/8X=?2_P.\,)>?"75HKV#R8];EGB^T1;?,>#8(NO.,-YN P
MX.3C!Y^<+^QN-,U&YL+R/R[JUE:&9-P.UU)##(X."#TH KT444 ?8?P=U]?$
M'PRTIMT?GV*?89E1& 4QX"=>I,?EDD<9)Z=!WE?-'[.WB>2R\47?AV>?%KJ$
M1E@C;<?WZ#)VXX7*;B21SL49X /TO0 4444 %%%% !1110 4444 %%%% !11
M10!Y_P#&N\^Q_"C6,)N:;RH5S!YJC,BY)X(7@'#'&&VX(;;7R!7TO^TC=HG@
MW2;(C]Y+J'FJ=Z]$C<'Y<[C]\<@$#N02N?FB@ HHK4L-(6_T35[];R-)]-2*
M8VS(V98F<1LRL. 59XN#U#DC[N" 9=%%% '4?#G6?[ ^(N@ZB7@CC6[6*62<
MX1(Y/W;L3D8PKL<G@8YXK[7KX K[7^'7B&X\4_#_ $?6+Q<74T128Y'SNC-&
MS\  ;BI; '&<=J .HHHHH **** "BBB@#R?]H#Q#;Z9\/_['9=]UJTJI&,D;
M4C99&?I@X(1<9'W\]C7RQ7K'[0'B&XU/X@?V.R[+728E2,9!W/(JR,_3(R"B
MXR?N9[FO)Z "BBMS4-"6Q\':)K)>0RZE<72;2K!0D7E 8RHR=S/DJ6'0<$,*
M ,.BBB@#K/ACJ4VE?$WP[<0+&SO>I;D."1ME_=,>".0KG'OCKTK[3KX(L+N3
M3]1MKV(9DMY5E4;V3)4@CYD(8=.JD$=B#7WO0 4444 %%%% !1110 4444 %
M%%<OXZ\=:7X#T,W]^?-N),K:6B-A[AQV'HHR,MVSW) (!U%8<_C3PK:W$MO<
M>)=&AGB<I)')?Q*R,#@@@MD$'M7R1XS^(WB/QTZ+J]S&MI$^^*SMTV1(VT#.
M,DL>O+$XW-C .*Y.@#[CTSQEX9UE(VT_7]-N#(B.(UN5W@.RJNY"=RDLZK@@
M'+ =3BMRO@"O1/ _QB\1^#GCMYY9-5TE$*BRN)<%/E 79(02H&T?+RN,\ G(
M /KNBL?PQXGTOQ=H<.KZ1/YMO)PRMP\3CJCCLPS^H()!!.Q0 4444 %%%% !
M1110 4444 ?#'BO1O^$>\6ZMI 2=([2[DBB\\8=HPQV,>!G*[3D#!SD<5CUZ
MQ^T'HW]G_$5=11)_+U*TCE:1Q\AD3]V54X[*L9(Y(W>A%>3T %>B?!#56TSX
MJ:8GVF.""]26UFWE0'!0LB9/0F18\8Y)P.^#YW5BPOKC3-1MK^SD\NZM95FA
M?:#M=2"IP>#@@=: /O>BHX)X;JWBN+>6.:"5 \<D;!E=2,@@C@@CO4E !111
M0 445P_Q>UG^Q/A?K4JO )KF(6<:3'[_ )I",%&1E@A=A_NYP0#0!\F>)=2A
MUGQ5J^J6ZR+!>WLUQ&L@ 8*[E@#@D9P?4UET44 6+.QN-0G:&UC\R18I)B-P
M&$C1I'//HJL??''-5Z]$^".ES:G\3[((DA@@M[A[EHY3&R1M$T>0P(8'=(HR
MIR,Y[9'!W]I)I^HW-E*<R6\K1,=C)DJ2#\K@,.G1@".X!H KT444 ?;?@#7V
M\4> ]&U>5I&GGMPL[NBJ7E0E)&PO !96(QC@C@=*Z2O$_P!G+Q!#<^&M0\/R
MW$C7=I<&XBCD<$"%P!A!G. X8M@8!D'=J]LH **** "BBB@#PS]I/65CT;1M
M"$$A>:X-X9B&"J$4H%!QAB?,).#E<#(^85\YUZ1\<]9_M?XH7L2O!)#I\4=G
M&\)SG WL&.3\P=W4],;<8R#7F] !6AH6F?VWXATS2?.\G[==Q6WF[=VS>X7=
MC(SC.<9%9]>H? '3/M_Q0@N?.\O^S[2:YV[<^9D"+;G/'^MSGG[N.^0 ?5]%
M%% !1110 4444 %%%% !116/XJ\0V_A3POJ&N72[H[2(N$R1YCDX1,@'&YBH
MSCC.3Q0!\N?&W7UU[XFWRQ-&T&G(MC&RHRDE,E]V>I$C.,C P!UZGSNBB@ K
M</AUAX%3Q,)9"C:FVGF,1KM4B(2 EMV<G)P I'RG)' .'7T^G@K^T/V:K72(
MS]INAIXU*V*VV]Q(Q,X1%SG<0QCR.3N/'.* /F"BBB@"2">:UN(KBWEDAGB<
M/')&Q5D8'(((Y!![U]S^&];A\1^&M-UF#RPEY;I*4202"-B/F3<.I5LJ>!R#
MP*^%*^E_V<_$-QJ'A?4=#G7,>ERJ\#Y'"2ER4P!V96.23G?C@ 4 >T4444 %
M%%% !1110 4444 %%%% !1110 5XO^TBW_%&Z2OFSC.H9\M8\QMB-^6;;PPS
MP-PR&8X.W*^T5XO^TBW_ !1NDKYLXSJ&?+6/,;8C?EFV\,,\#<,AF.#MRH!\
MT4444 %?>>DO-+HUC)<&1IWMXVD,@(8L5&<@HA!S_L)_NKT'P97W?H4?E>'M
M,C\OR]EI$NS9LVX0<;=B;?IL3']U>@ -"BBB@ HHHH **** "BBB@ HHHH *
MS]=1)/#VII*\"1M:2AFN&58U&PY+EU90OJ65ACJ".*T*S]=D\KP]J<GF>7LM
M)6W[]FW"'G=O3;]=Z8_O+U !\(4444 %?3?[-\$*^!=3N%BC$\FILCR!1N95
MBC*@GJ0"S8';<?6OF2OI?]FY$'@W5I!9[)&U##76%_> 1IA,YW?+DGD8_><$
MG=@ ]HHHHH *XOXD_$"T\ ^'VG/ER:I<(PL+:17VRL"H8DJ, *'#8)&<8![C
MI-<UFS\/:'>ZO?OLM;2)I7P0"V.BKD@%B< #/)(%?&'C3Q9>>-?%%UK5XGE>
M;A(8!(66&-1A5!/XDXP"Q8X&<4 8]_?7&IZC<W]Y)YEU=2M-,^T#<[$EC@<#
M))Z57HHH *Z3P/X,OO'7B6/1[&2.$!#-<3OR(8@0"V.K'+  #J2,X&2,?2M*
MOM;U2WTS3+:2YO+A]D42#EC_ "  R23P "3P*^Q_A]X'L? OAJ&Q@BC-_*BO
M?W .XS2XYP2 =@)(48&!SU)) -S0]&L_#VAV6D6";+6TB6),@ MCJS8 !8G)
M)QR236A110 4444 %%%% !1110 4444 >=_'&"&;X2:N\L4;O"\#Q,R@E&\Y
M%ROH=K,,CL2.]?(E?6_QU7=\*-2/E3OME@.Z*3:J?O%&7&X;EYQC#?,5..-P
M^2* "BBB@#[7^'")'\-?#@CL_LBG3X28\*-Q*@E_E)'SDE_7YN0#D5U%<O\
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M$Y"9P 37U'7P!7UW\'?'"^,?!T<%Q+(^K:8B07A<-\XY$<FXD[BRKR<YW!N
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MCO0!)1110 4444 %%%4[W5M-TUXTO]0M+5Y$D>-9YE0LJ+N<C)Y"KR3V')H
MN45CCQ9X;-Y#9CQ!I1NIMGE0B]CWR;P"FU<Y.X,I&.N1CK6Q0 4444 %%%%
M!1167/XET&U,HN-;TV$Q(7D$ETB[%$GE$G)X D^3/][CKQ0!J45ECQ+H+7#V
MZZWIIGCN%M7C%TFY9F)"QD9R')5L+U.T^E5Y/&GA6%(7E\2Z,B3)OB9K^(!U
MW%<K\W(W*PR.X([4 ;E%4[;5M-O+B2WM=0M)YXWD1XXIE9E9"H<$ Y!4NF1V
MW#/45<H **** /@"BBB@ K[_ *^ *^_Z "BBB@ HHHH **** "BBB@ HHHH
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M10 5[Q\6/#">'_@IX/MG@^SW5E*D4T/ROB66)WE^?D_?4\*VTYZ'"X\C\':
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M'IR<_,GQ$^']Y\/M<BL9KC[9:W$0EM[L0F,/V92#D!@>H!/#*>,XK[/KQ/\
M:3CMCX5T:5YHQ=K>E8XB$W,A0[V&1OP"$!P0/F&03MP <)\!O&%QHWC2/0IK
MG&F:IN3RY)0J1S@91QD?>;;LP"-VY>NT"OJ>OACPG<_8_&6AW6Z!?)U""3-Q
M+Y48Q(I^=\':O'+8.!S@U]ST %%%% !1110 4444 %%%% 'B_P"T=HWVOPEI
MFKHD[R6%V8FV#*)'*O+-QQ\R1@'('S8Y)%?-%?:_Q&T;^W_AUKVG!)Y)&M&E
MBC@&7>2/]XB@8.<LBC Y.>.:^** "BBB@#Z_^"VM_P!M_"_2]]QYUQ8[K*7Y
M-NS8?D7H <1F/D9]SG->@5X!^S7K?_(<T&6X_N7MO!L_X!*V['_7$8)^@ZU[
M_0 4444 %>"?M)Z^HM]&\.1M&79S?3J4;<H *1X/3!S+D<GY1T[^]U\B?&W7
MUU[XFWRQ-&T&G(MC&RHRDE,E]V>I$C.,C P!UZD \[HHHH ]P_9KL4D\0ZY?
MF.<R0VB0JZLOEJ'?)##[VX^6,8XP&SR5KA_C!8V^G_%?7X;6/RXVE28C<3EY
M(TD<\^K,Q]L\<5[?^SYH\FG_  Z:_D?=_:5W)+&HE8A43]WRI^56W(^2.HVY
M/  XC]I33/*\0Z'JWG9^TVCVWE;?N^4^[=G/.?.QC'&WOG@ \/HHHH ]0^ F
MLWFG_$RVTZ%_]%U**2*XC).#L1I%8 '&X%< G. S>M?5]?!FDW[:5K-CJ*&0
M/:7$<Z^6RALJP;@LK 'CNI'J#TK[KL+ZWU/3K:_LY/,M;J)9H7VD;D8 J<'D
M9!'6@"Q1110 5'//#:V\MQ<2QPP1(7DDD8*J*!DDD\  =ZDKB_BQK<.A_#+7
M)I?+9[FW:SBC:0(7:7Y/E]2JEGP.H4].H /D37-6N-=UR]U2ZFGEFN96D+3R
M!WQ_""0%' P.%4<< #BL^BB@ KZ3_9LTV&+PKK.J*TGGW%Z+=U)&T+&@92.,
MYS*V>>P_'YLK[3^&>B3>'OAOH>G7'F>>MOYLBR1F-HVD8R%"IY!4OM_#H.E
M'64444 %%%% !1110 4444 %>&?M&^*%@TO3_"\$D@GN7%Y<[791Y2Y5%88P
MP9LGKP8AQR#7N=?&GQ5\4-XK^(.HW:R1O:6SFSM#&ZNIBC) 8, -P9BS]_O8
MR0!0!Q=%%% &YX.T!O%/C'2M%59"EU<*LOELJLL0^:1@6XR$#'OTZ'I7W'7S
M9^S?HD-WXEU;69?+9["W2*)&C!(:4GYU;^$A8V7@<ASSZ_2= 'PYXQT!O"WC
M'5=%99 EK<,L7F,K,T1^:-B5XR4*GMUZ#I6'7O'[1WAA(+S3/$]M!M^T9M+M
MQM +@9C)'WBQ4.">>$4<<9\'H *[SX.Z^WA_XFZ4VZ3R+Y_L,RHBDL),!.O0
M"3RR2.< ]>AX.B@#[_HKF_ &OMXH\!Z-J\K2-//;A9W=%4O*A*2-A> "RL1C
M'!' Z5TE !1110 4444 %%%% !1110 4444 %>+_ +2+?\4;I*^;.,ZAGRUC
MS&V(WY9MO##/ W#(9C@[<K[17B_[2/E?\(;I.?/\[^T/EV[_ "]OEOG=CY-V
M=N,_-C=MXW4 ?-%%%% !7WGI,30Z-8Q/;QVSI;QJT$<2QK&0H^4*K,% Z8#,
M!C )ZU\&5]WZ%'Y7A[3(_+\O9:1+LV;-N$'&W8FWZ;$Q_=7H #0HHHH ****
M "BBB@ HHHH **** "L_79I;?P]J<\%S]EFCM)72?"'RF"$AL2%4X//S$+QR
M0.:T*S]=D\KP]J<GF>7LM)6W[]FW"'G=O3;]=Z8_O+U !\(4444 %?3?[-\*
MKX%U.<&3>^ILA!D8KA8HR,+G /S') R>,YP,?,E?3?[-\$*^!=3N%BC$\FIL
MCR!1N95BC*@GJ0"S8';<?6@#V2BBO /CC\4/^/GP=HD_HNH74$W^\'MR-O\
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ME,SRPQ^3([G.2SQ[6;.23D\GGK7SA\6/A?\ \*_O+6YL)Y[K2+O*(\RY>&0
M95V "G/)7H3AACY<D ^C_ OCK2_'FAB_L#Y5Q'A;NT=LO;N>Q]5.#AN^.Q!
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M<8+( ><G'F,O!!KM_B1\;M+T73I;#PM>P:AJ\GR?:(OWD-L" =^[[LC<\ 9
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M.""#R"#VJ.@ KZ_^"VLRZS\+]+,[[YK/=9LV4^ZAP@PIXPA0?, QQG!!#'Y
MKWC]FO5=NHZYHY$'[R)+I3MQ(=IVGD+\R_.O!88)^53N8@ ^AZ*** "O$/VD
M=9O+30]%TB%]EK?RRRW&"07\K9M4X."N7R00>54\8KV^OE#X_:G]O^*$]MY/
ME_V?:0VV[=GS,@R[L8X_UN,<_=SWP #R^BBB@#4\-Z)-XC\2Z;HT'F![RX2(
MND9D,:D_,^T=0JY8\C@'D5]UU\J?L^Z;#??$T7$K2!["REN(@I&"QVQ8;CIM
MD;ICD#Z5]5T %%%% !1110 4444 %%%% '-^/]?;POX#UG5XFD6>"W*P.B*Q
M25R$C;#<$!F4G.> >#TKXDKZ _:4UO\ Y >@Q7']^]N(-G_ (FW8_P"NPP#]
M1TKY_H ***Z3P!H"^*/'FC:/*L;03W :='9E#Q("\BY7D$JK 8QR1R.M 'U/
M\*/#\WAKX;Z397=M'!>2(UQ<*J%6W.Q8!\@'>%*J<]-N.@%=I110!Q_Q1\._
M\)/\.M7L8XO,NHXOM-L%A\U_,C^8*@Z[F *9'/SGKT/QA7W_ %\4?$7P];^%
MOB!K&CV;9M890\(P?D1U614Y))VA@N2><9[T <O1110!]"?LV:^IM]9\.2-&
M'5Q?0*$;<P("29/3 Q%@<'YCU[>]U\2> -?7POX\T;5Y6C6""X"SNZ,P2)P4
MD;"\DA68C&>0.#TK[;H **** "BBB@ HHHH **** "BBB@ KQO\ :0,W_""Z
M8JQQF ZFI=RY#!O*DV@+C!!&[)R,8'!SQ[)7B_[2(M_^$-TDM!FZ&H8CE\DG
M:GEON7?C"Y.P[<C=MS@[3@ ^:**** "ON_0H_*\/:9'Y?E[+2)=FS9MP@XV[
M$V_38F/[J]!\(5]WZ$B1^'M,2)X'C6TB"M;LK1L-@P4**JE?0JJC'0 <4 :%
M%%% !1110 4444 %%%% !1110 5GZ[)Y7A[4Y/,\O9:2MOW[-N$/.[>FWZ[T
MQ_>7J-"LOQ+=+8^%=7NW>1$@LII6:/=N 5"<C:R'/'9E/HPZT ?"E%%% !7T
MO^S<O_%&ZLWE3C.H8\QI,QMB-.%7=PPSR=HR&49.W"_-%>\?"+Q9!X*^$OB#
M6KU)Y88M0"6\'F1*DTS(@VH?O[L8+9R H!4$AA0!Z'\6?B-#X(\/O;V5S&/$
M%VG^B1[ _EKG!E89P !G;G.6[$!L?)$\\UU<2W%Q+)-/*Y>221BS.Q.223R2
M3WK0\1Z_?>*?$%YK6I-&;NZ<,_EIM50 %50/0* .<GCDD\UET %%%=9\/O ]
M]XZ\2PV,$4@L(G5[^X!VB&+/."01O(!"C!R>>@) !T'P@^&:^.M4FOM3,B:+
M8NHE50P-RYY\L-T  P6(.0"H&-VX?6=4]*TJQT32[?3-,MH[:SMTV11(.%'\
MR2<DD\DDD\FKE !1110 4444 %%%% !1110 4444 %%%% 'F_P =99(_A1J2
MHV%DE@5QY#2;AYBG&X'$?(!W-D<;>K"ODBOK?XZI<-\*-2,#[8UE@,XW ;D\
MQ0!@J<_,5. 5Z9S@%6^2* "BBB@#[7^' MQ\-?#@M8/)C_L^$E?),>7VC>V"
M!G+;CN_BSN!(.3U%<W\/C,WPY\-F>.-'_LRW ".6&WRQM.2!R5P2,<$D9.,G
MI* "BBB@ HHHH **** "O)_VAFV_#6,>; F[4(AMECW,_P KG"':=K<9SE?E
M##/.T^L5Y/\ M#-M^&L8\V!-VH1#;+'N9_E<X0[3M;C.<K\H89YVD ^6****
M -#0H_-\0Z9'Y?F;[N)=FS?NRXXV['W?38^?[K=#]WU\&:3=+8ZS8W;O(B07
M$<K-'NW *P.1M9#GCLRGT8=:^\Z / /VB?!O_'IXOLH?2UO]B_\ ?N0X7ZH6
M8_\ /,"OG^OO>_L;?4].N;"\C\RUNHFAF3<1N1@0PR.1D$]*^)/%WA>^\'^)
M;O1[^.0&)R8963:)XLG;(O)&"!TR<'(/(- &'1110!<TK5;[1-4M]3TRYDMK
MRW??%*AY4_R((R"#P02#P:^U_"/BBQ\8>&K36+"2,B5 )HE?<8)<#=&W .03
MUP,C!'!%?#E>L? OQU)X=\4+H%T<Z;J\JQ@LS'R9\$(549'SDJAX'\)) 7D
M^IZ*** "OGC]I=+@:CX==GS:F*<1KN'#@IN.-N1D%.=QSCHN"6^AZ\ _::_Y
ME;_M[_\ :- 'S_1110!V'PK\C_A:'A[[1]S[6,?ZK[V#M_UGR_>QT^;^Y\^V
MOL^OC3X2B[;XJ>'Q922)+]H)8HB,?+V-Y@PQ P4W G.0"2H) !^RZ "BBB@
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M![RX2(ND9D,:D_,^T=0JY8\C@'D5]SP00VMO%;V\4<,$2!(XXU"JB@8  '
M':OG3]G'P[]IUS4_$,T68[.(6UN7AR#(_+,KGHRJN"!SB7L#S]'T %%%% &7
MXDT2'Q'X:U+1I_+"7EN\0=XQ((V(^5]IZE6PPY'('(KX8G@FM;B6WN(I(9XG
M*21R*59&!P00>00>U??=?*'QY\._V+\19+Z*+9:ZK$MRI2'8@D'RR*#T9L@.
M3U_><^I /+Z*** /7/V>M?;3?'DND,TGD:K;LH144CS8P75F)Y "^:..[#([
MCZCKX(L+ZXTS4;:_LY/+NK659H7V@[74@J<'@X('6ON^POK?4].MK^SD\RUN
MHEFA?:1N1@"IP>1D$=: +%%%% !1110 4444 %%%% !1110 4444 ?!%_*D^
MHW,L3;XWE9E;R%AR"20?+0E4_P!U3@=!Q5>K%^\DFHW,DMY]MD:5BUUECYQ)
M.7RX#'/7Y@#SR,U7H *^B/V:%_XEWB)O*@&98!YBR9D; ?AEW<*,\':,EF&3
MMPOSO7T1^S0W_$N\1+YL!Q+ ?+6/$BY#\LVWE3C@;C@JQP-V6 /=Z*** "BB
MB@ HHHH **** "BBB@ KS?XZKN^%&I'RIWVRP'=%)M5/WBC+C<-R\XQAOF*G
M'&X>D5YO\=?*_P"%4:EYGG[O-@\ORM^W=YB_?V\;<9^_\N[;_%MH ^2****
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MYK.KQ-&T$]P5@=$90\2 )&V&Y!*JI.<<D\#I7-T44 %?0'[->B?\AS7Y;?\
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MC8JR,#D$$<@@]ZCHH ]H\'?M!ZS87GE>*U_M.Q;<3-!"B3QG V@ ;49<@\$
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MC_Q%M+:4P+:ZI_H<KO#N<,?]6%8#*Y?8#_"<Y(X! !];T444 %%%% !1110
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MH(9L?1]?.G[-)/\ ;.OKY<A!MXB7#R!1\S<%0-A)[%B&&#M!!?'T70 4444
M%%%% !1110 4444 >-_M%:^VG^#K'18FD5]4N"TF$4JT46&*DGD'>T1&/[IY
M['YDKT3XVZ^NO?$V^6)HV@TY%L8V5&4DIDONSU(D9QD8& .O4^=T %:&A:9_
M;?B'3-)\[R?MUW%;>;MW;-[A=V,C.,YQD5GU[1^SGH"7WBC4=;>?:VF1+&D7
ME*V\RAQG<02N A^[@G=C.,A@#Z/L+&WTS3K:PLX_+M;6)884W$[44 *,GDX
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M2XCCWZBXAM244L(HR0Q#9R S\%<#_5 \Y%>V4 %%%% !1110!\>?&+0&\/\
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MPU#?02QB_B14O[<#:89<<X!).PD$J<G(XZ@@ '64444 %%%% !1110 4444
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M:OONOG#X_> OL&HQ^*]*LMMI<_+J'DI\L<V>)&YXWYP2 !N7))+\@'A]%%%
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MJCY6R,_Q?*,$<Y%^.OCY?+SJD#;(GC;-I'\['=AS\OWEW#&,+\BY!^;/F]%
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M\X+E1VZ]1UK<KQ#]H[Q%]FT/3/#T,N)+R4W-P$FP1&G"JR#JK,V03QF+N1P
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M@ Y.O7/A;\9;GPN\&C:\TESHK/@7#,\DMJ-JJH4$D>4H7[@&1DD9QM/H^L_
M70+KP5#IFF+';:U;H'74#NQ<2[5#>8"6(1BN<#[A.1U8-\Z>)_#&J>$=<FTC
M5X/*N(^59>4E0]'0]U./T((!!  /M^QO[/4[..\L+N"[M9,[)H)!(C8)!PPX
M.""/PJQ7QAX%^)&N^ [P?89O.TV2427-A)C9+Q@X."4;'\0_NKD,!BOKOPYK
M]CXI\/V>M::TAM+I"R>8FUE()5E(]0P(XR.."1S0!J4444 %%%% !1110!Y/
M^T'HW]H?#I=11(/,TV[CE:1Q\XC?]V54X[LT9(X!V^H%?+%?<_BO1O\ A(?"
M6K:0$@>2[M)(HO/&460J=C'@XPVTY R,9'-?#% !1110!]C_  AUG^V_A?HL
MK/ 9K:(V<B0G[GE$HH89.&*!&/\ O9P 17B'[0>L_P!H?$5=.1Y_+TVTCB:-
MS\@D?]X649[JT8)X)V^@%=W^S9?K)X5UG3@8]\%Z)SAFW8D0*,C;C'[LXPQ/
M7(& 6\,\<ZS%X@\<ZUJMN_F6]Q=N87RYW1@[4/SDL,J << = %   !S]%%%
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M.2I.>@+$J%(7;P=%% !1110!ZY^SUK[:;X\ETAFD\C5;=E"*BD>;&"ZLQ/(
M7S1QW89'<?4=?!%A?7&F:C;7]G)Y=U:RK-"^T':ZD%3@\'! ZU]UZ3J4.LZ-
M8ZI;K(L%[;QW$:R !@KJ& ."1G!]30!<HHHH **** "BBB@ HHHH *\7_:1\
MK_A#=)SY_G?VA\NW?Y>WRWSNQ\F[.W&?FQNV\;J]HKQ?]I%O^*-TE?-G&=0S
MY:QYC;$;\LVWAAG@;AD,QP=N5 /FBBBB@ K[K\-/#+X5TB2W,;0/90M&8P I
M4H,8 1 !C_83_=7H/A2ON_0I/-\/:9)YGF;[2)M^_?NR@YW;WW?7>^?[S=2
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MS6/7T_\ '[P;_;/A>/Q#9P[K[2O]=L7+26Y/S9PI)V'#<D!5,AKY@H ****
M/H#]G;QE_P ??A"]F];JPWM_W\C&6^CA5'_/0FMO]I"-CX%TR432!%U-5,0"
M[6)BDPQXSD8(&"!\QR#QCYTT/6;SP]KEEJ]@^RZM)5E3)(#8ZJV""5(R",\@
MD5[Y\:];A\1_!CP]K,'EA+R]@E*)()!&QAEW)N'4JV5/ Y!X% 'SG1110!V'
MPK=$^*'AXR) Z_:P )U5ER00" S*-P."ISD-@@,<*?L^OC#X5W'V;XH>'I/M
MWV+-V(_-\GS-VX%?+QVWYV;OX=V>U?9] !1110 4444 %%%% !1110 4444
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M5% R22>  .]?$'C'79O$OC'5=7FECD-Q<,4:/.WRQ\J 9520%"C)4$XR1G-
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MRQF.)P,#F-6PO(P. 10!\245)/!-:W$MO<120SQ.4DCD4JR,#@@@\@@]JCH
M*^H_V>M?74O <ND,T?GZ5<,H148'RI"75F)X)+>:..RC([GY<KTCX(^)Y/#_
M ,1;2UDG\NQU7_1)E.X@N?\ 5$ ?Q;\*"0<!VZ9R #ZWHHHH **** "BBB@
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MS$,9,%.O0B/RP0.,@]>I .\HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** /@"BBB@ K['F^,'@&#[1O\
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M0 5YO\=?*_X51J7F>?N\V#R_*W[=WF+]_;QMQG[_ ,N[;_%MKTBO-_CKYO\
MPJC4O+\_;YL'F>5LV[?,7[^[G;G'W/FW;?X=U 'R11110 5]I_#$EOAEX=)C
MD3_0D&'>1C]<R '!Z@ ;0" I*A2?BROM/X8Q-%\,O#JO;QP$V2-L2)4!!Y#8
M5F&6!W$YR222%)*@ ZRBBB@ HHHH **** "BBB@ KXH^(\J3?$KQ&T;;E&H3
M*3Y"Q<AB"-JG!P01NZM]XX)-?:]?%'Q'>23XE>(S)>?:V&H3 298[0&("?,
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MCW) '>@#[?\ !D+6W@7P] YC+QZ9;(QCD5U)$2CAE)##W!(/:MRBB@ HHHH
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M_P"!M&B\/^!M%TR)-GDVB&08<9D8;G.' 89=F." 1G&!C Z"@ HHHH ****
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M>/\ 6KG/3#YQL?: <?178)\*_'+Q-(/#-]M6(S$%0#M"HQ !.2V'7"CYB0P
MRK 2#X2^/&+@>&KOY'5#ED'+2&,8^;D;E))' 7#'"D,0#Z/^#NOKX@^&6E-N
MC\^Q3[#,J(P"F/ 3KU)C\LDCC)/3H.\KQ/X&Z%XK\(ZIJ^CZ[I%W;6<Z":.5
MI0T22IMW!=N5)995^8'GRB.2IV^V4 %%%% !1110 4444 %%%% 'P1?MOU&Y
M;S8)=TK'S+>/RXWY/*+M7:I[#:,#C Z57KO-2^%7CAM9NU3P[=N&N&"NL442
MG+)@[48H@_>KPI*KA^<1MMKS_"7QY;"4OX:NSY;E&\MD?)$?F<;6.X;>,C(+
M?*/F^6@#BZ^B/V:/-_L[Q%GR/)\V#;MV>9NP^=V/GVXVXS\N=VWG=7E<_P )
M?'EL)2_AJ[/EN4;RV1\D1^9QM8[AMXR,@M\H^;Y:]K^ _A76/"]GKD>M:9]B
MGFECV%P^]U0R+R?]65!#8V_-SD_*T9(![!1110 4444 %%%% !1110 4444
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M,J#'7.X=4?: ?3=%%% !1110 4444 ?+G[0NA+IWCR+58WD8:I;J[JRMA7C
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MA5E\ME5EB'S2,"W&0@8]^G0]*^XZ^>/@K\.M=T7Q]+J.OZ)/:QVEI)]GED8
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M+JWU!(YG,4:Q1QRE7# L2 2?*+EN.9 #RR[@#Q.BNP?X5^.4B60^&;[:T0F
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MYJ7AGPUJ=GK%C=V=\]ZS^7*6*&,#8"O)3)9),D<D;"<J4) /5**** "BBB@
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M\-^W&Y0OWO+QG)X_UJYSTP^<;'V@''T5V"?"OQR\32#PS?;5B,Q!4 [0J,0
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 5X_\>?\ D!R?]@J?_P!+=/HHH ^8****
M /0/A'_R,\__ &X_^G*SKZ_HHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g201806011825107951022.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g201806011825107951022.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "Q"F<# 2(  A$! Q$!_\0
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MEB61H\-\A(!(^=5;C_:53Z@'BO@BOO/23"VC6+6\=I' ;>,QI9N'@5=HP(V
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M4A#G)VJ,$-EB']H+QN2A!TT;79B!;'Y@9 X4_-T"@H,8.UCDEL,/*Z* /O\
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M[&'7/[U^>$V^G_M"ZV+#P'%I8\S?J5PJY62,#;&0YW*V789V_= P<989"O\
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M.FL52)2QMCEBC99CAL9<<-C  ^Z%/-$7[07C>-X&8Z;((D175[8XE(5@6;#
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MV,N.&Q@ ?="GFO*Z* /4'^/WCEHE07%BC+$(RXM1EF"NI<Y.-Q+*QP-N8UP
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MIV_VSK^;6-G^SQ8N"C;HQN;* [< -P2"P)V# ;!*_1= !1110 4444 %%%%
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M!@  <  =JDH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M&.%*_P 5>J5YG\>21\*[P".1LW$()5Y%"_..6"@AAVPY"Y(.=P4$ ^3****
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M$L?8 D]JPZW/!D;3>.O#T2320.^IVRK+&%+(3*OS#<",CKR"/4&@#[CHHHH
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MLS'SHBL9!*+N^<%B =Q9L9/'3 !ZI1110 4444 %%%% !1110 4444 %%%%
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MW&TY'&#TKX8K[G\62I!X-UR65MD::?.S-Y"S8 C8D^6Y"O\ [K'!Z'BOAB@
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M+D^4LYZ;5)#X/'R#IU'V?7P!7VO\.O$-QXI^'^CZQ>+BZFB*3'(^=T9HV?@
M#<5+8 XSCM0!U%%%% !1110 4444 %%%% !1110 4444 %?+'[0S;OB5&/-G
M?;I\0VRQ[53YG.$.T;EYSG+?,6&>-H^IZ^6/VAFW?$J,>;.^W3XAMECVJGS.
M<(=HW+SG.6^8L,\;0 >3T444 =I\)7FC^*GA]H#('-P5)0$G:48-T1^-I.>!
MQGYD^^OV77QA\*X_,^*'AY?+\S%V&QLW] 3G&Q^F,YP,8SN3&]?L^@ HHHH
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MC(XX)'- &I1110 4444 %?''Q@;=\5]?/FSR_O4&Z>/8PQ&@P!M7Y1T4XY4
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MN<[F ) ZG'% &A167IOB70=9N&M]+UO3;Z=4WM':W22L%R!DA23C)'/N*U*
M"BBB@ HHHH **CGGAM;>6XN)8X8(D+R22,%5% R22>  .]9[^)=!C=T?6]-5
MT>5&4W2 JT2[I0>>"B\L/X1R<4 :E%8__"6>&_(\_P#X2#2O)\KS_,^VQ[?+
MW^7OSG[N_P"7/3=QUH/BSPV+R:S/B#2A=0[_ #83>Q[X]@)?<N<C:%8G/3!S
MTH V**KVE_9ZA$9;*[@N8QMR\,@<#<H=>1ZJRL/4,#T-6* "BBB@#X HHHH
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M\^W&9(L1L=R#*_,.HY'(ZCK7PQ7W/XL>2/P;KDD5Y]BD73YRMUEAY)$;8?*
ML,=?E!/' S7PQ0 4444 ?6?P&29/A79M*L@1[B9HBQ)!7>1\OSM@;@W0)SGY
M3]]_3*\O^ ,>SX7P-Y>W?=S-G9MW\@9SL7=TQG+],;AC8GJ% !1110 4444
M%%%% !1110 4444 ?/G[2>OL;C1O#D;2!%0WTZE%VL22D>#UR,2Y' ^8=>W@
M==!XYUO_ (2/QSK6K+<?:(9[M_(EV;-T*G;'Q@8^0*.1GUYS7/T %=9\,]&7
M7_B1H>GO/) AN/.9XRRMB)3)@,I!4G9C<#D9R.E<G7T)^S?X<FA35O$5S8R(
MDR);65RQ(#KN)E"C/(W+'\V.H(!X84 >YW]C;ZGIUS87D?F6MU$T,R;B-R,"
M&&1R,@GI7PIJVFS:-K-]I=PT;3V5Q);R-&25+(Q4D9 .,CT%?>=?,'[1.B?8
M?'-IJT=OLAU*T&^7?GS)HSM;C/&$,0Z 'ZYH \?HHHH ]0^ WB+^Q?B+'8RR
M[+758FMF#S;$$@^:-B.C-D% .O[SCT/U?7P)!/-:W$5Q;RR0SQ.'CDC8JR,#
MD$$<@@]Z^Y_#>MP^(_#6FZS!Y82\MTE*)()!&Q'S)N'4JV5/ Y!X% &I1110
M 4444 %%%% !1110 4444 %%%% 'QI\6K]=2^*GB"=#'A+@0?(S$9C18S]Y5
M.<ISQC.<%AACQ=7-6OVU76;[47,A>[N))V\QE+99BW)55!//90/0#I5.@ KV
MC5M&_M#]ES0-11(/,TV[DE:1Q\XC>XEC*J<=V:,D< [?4"O%Z^P])T!=:^!E
MCHL:QR/>:%&L7VMFD597B#*Q)R0%<@C'W<#:!@"@#X\HHHH *^P_@[KZ^(/A
MEI3;H_/L4^PS*B, ICP$Z]28_+)(XR3TZ#X\KW#]G'Q%]FUS4_#TTN([R(7-
MN'FP!(G#*J'JS*V21SB+N!P ?1]%%% !1110 5Y_\:=;_L3X7ZILN/)N+[;9
M1?)NW[S\Z]"!F,2<G'L<XKT"OFS]HWQ!-<^)=/\ #\5Q&UI:6XN)8XW)(F<D
M8<9QD(%*Y&0)#V:@#Q.BBB@#H/ VB?\ "1^.=%TEK?[1#/=IY\6_9NA4[I.<
MC'R!CP<^G.*[C]H:T2V^)4<J'+76GQ2O\BC!#.G4 $\(.6)/;.  )/V>M ;4
MO'DNL,LGD:5;LP=64#S9 456!Y(*^:>.ZC)['H/VF(56X\-3@R;W2Y0@R,5P
MIB(PN< _,<D#)XSG P >!T444 =!X%ODT[Q]X?NY9((H8]0@,LDZJ41"X#,=
MW P"3N_AQD$$ U]OU\ 5][V%];ZGIUM?V<GF6MU$LT+[2-R, 5.#R,@CK0!8
MHHHH **** "BBB@ HHHH Q_%7B&W\*>%]0URZ7=':1%PF2/,<G")D XW,5&<
M<9R>*^(+^^N-3U&YO[R3S+JZE::9]H&YV)+' X&23TKZO^.KW"_"C4A FZ-I
M8!.=H.U/,4@Y+#'S!1D!NN,8)9?DB@#W#X/_  ?TOQ-H:^(O$2SRV\LKI:VB
M2;$D1<J78J=WW\@ %<;,G(:O;_\ A!/!_P#T*FA_^"Z'_P")J3P9&L/@7P]$
MDT<Z)IELJRQA@K@1+\PW '!Z\@'U K<H \S\6_ _PIXBMY7TZVCT74'=6%Q:
MH3& !@J8=P3!']W:<X.3R#\N:YHUYX>UR]TB_39=6DK1/@$!L=&7(!*D8(..
M00:^[Z^5/V@H[9/B:6@FCDDDLHFN%4)F-_F 5MH!SM"'YLG##G;M  /0_P!G
MOQA<:OH=[X>O[GS9M-V/:&24%S W&P+C)5"!SDX\Q5X %>T5\L?L\W/D?$J2
M/= //T^6/$LNQCAD;Y!@[V^7[O'R[CGY<'ZGH **** "BBB@ HHHH **** /
MEC]H/1O[/^(JZBB3^7J5I'*TCCY#(G[LJIQV58R1R1N]"*\GKZ7_ &CM&^U^
M$M,U=$G>2PNS$VP91(Y5Y9N./F2, Y ^;')(KYHH *L6%]<:9J-M?V<GEW5K
M*LT+[0=KJ05.#P<$#K5>B@#[WL+ZWU/3K:_LY/,M;J)9H7VD;D8 J<'D9!'6
MK%>?_!;6_P"V_A?I>^X\ZXL=UE+\FW9L/R+T .(S'R,^YSFO0* "BBB@ KY$
M^-NOKKWQ-OEB:-H-.1;&-E1E)*9+[L]2)&<9&!@#KU/UG?WUOIFG7-_>2>7:
MVL333/M)VHH)8X')P >E?"FK:E-K.LWVJ7"QK/>W$EQ(L8(4,[%B!DDXR?4T
M 4Z*** /J?X(:)9W'P>>VN;>=K?59;C[2LK@+*I_='85.Y5VICG#;@Q'&#7R
MQ7W/X4T>3P_X2TG2)7\R:SM(XI6$K2 N%&[:6YVYS@<8&    !\D?%33/[(^
M*'B&V\[S=]V;G=MVX\X"7;C)Z;\9[XSQTH X^BBB@#Z0_9NUF\N]#UK2)GWV
MMA+%+;Y))3S=^Y1DX"Y3(  Y9CSFO;Z^1/@EKL.A_$VQ%Q+)'%?HUD2N,%GQ
ML##:207"C@K@D$G (/UW0 4444 %<7\5]>;P[\-]6O(;N2UNW18+9XIECD+N
MP'R$@\A=S' SA3@J?F':5X9^TGK<*:-HV@KY;3S7!O'Q(-T:HI1<KUPQD;!X
M^X>O8 ^<Z*** "OM/X8Z;#I7PR\.V\#2,CV27!+D$[I?WK#@#@,YQ[8Z]:^0
M/#>B3>(_$NFZ-!Y@>\N$B+I&9#&I/S/M'4*N6/(X!Y%?== !1110 4444 %%
M%% !1110 5\F?'/Q0OB'X@S6EO)(;324^Q@%VVF4$F5@I VG=\AZY\L')&,?
M3_B36X?#GAK4M9G\LI9V[RA'D$8D8#Y4W'H6;"C@\D<&OAR_OKC4]1N;^\D\
MRZNI6FF?:!N=B2QP.!DD]* *]%%% 'KG[/6@-J7CR76&63R-*MV8.K*!YL@*
M*K \D%?-/'=1D]C[_P"/] ;Q1X#UG1XED:>>W+0(C*I>5"'C7+< %E4'..">
M1UKC_@!HD.G?#>/45\MI]4N))781A6548QJA;JP!1F'3&\\=SZI0!\ 45W'Q
M;\,)X5^(NH6MM!Y-C<XN[51MP$?J%"XVJ'#J!@8"CKU/#T %>^?LV:^PN-9\
M.2-(49!?0*$7:I!"29/7)S%@<CY3T[^!UN>#M?;PMXQTK6E:0):W"M+Y:*S-
M$?ED4!N,E"P[=>HZT ?<=%%% !1110 4444 %%%% !1110 4444 %?+'[0S;
MOB5&/-G?;I\0VRQ[53YG.$.T;EYSG+?,6&>-H^IZ^6/VAO*_X65'Y?G[O[/B
M\SS=^W=N?[F[C;C'W/EW;OXMU 'D]%%% ':?"6)I?BIX?5+>.<BX+;'B5P $
M8EL,RC*@;@<Y! (#$!3]EU\8?"N/S/BAX>7R_,Q=AL;-_0$YQL?IC.<#&,[D
MQO7[/H **** "BBB@ HHHH **** "BBB@ KR_P"/TTL7POG2.Y\I9;N%)$PA
M\Y<EMOS$$<@-\@+?+TV[B/4*\O\ C])L^%\Z^9MWW<*XW[=_).,;UW=,XP_3
M.T8WH ?*%%%% !7VW\/H5@^'/AM$,A!TRW?YY&<Y:,,>6).,G@= , 8  KXD
MK[;^'T$-M\.?#:011Q(=,MW*HH4%FC#,>.Y8DD]R2: .DK+\1Z_8^%O#]YK6
MI-(+2U0,_EIN9B2%50/4L0.<#GD@<UH3SPVMO+<7$L<,$2%Y))&"JB@9))/
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M3**** "O9/@%XX;1_$!\+WDL:Z?J3EX"P4;+G  ^8D<,J[<<DML QDY\;HH
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MXZ[?FQTYK[WKX(L)4@U&VEE;9&DJLS>0LV ""3Y;D*_^ZQP>AXK[WH ****
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M@,#D$9X((K0H **** "BBB@ HHHH **** "BBB@ KA_C ]NGPHU\W2;X_*0
M;2WSF1 AP&7HVTYSQU(8?*>XKA_C!-Y'PHU]_M,]OF)$WP#+'=(B[3R/E;.U
MN?NL>#T(!\<4444 %?8_P?\ *_X51H'D^1M\I\^1OV[O,?=G?SNSG=CY=V=O
MRXKXXK['^#_E?\*HT#R?(V^4^?(W[=WF/NSOYW9SNQ\N[.WY<4 =Q1110 44
M44 %%%% !1110 4444 %?/G[3$;"X\-2F:0HR7*B(A=JD&++#C.3D Y)'RC
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M$8!3'@)UZDQ^621QDGIT'>4 %%%% !7PQXJ\0W'BOQ1J&N72[9+N4N$R#Y:
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M.51A@\'//%<O7M'[..C?:_%NIZNZ0/'86@B7>,NDDK<,O''RI("<@_-CD$T
M?2]?-G[2&B0VGB72=9B\M7O[=XI46, EHB/G9OXB5D5>1P$'/I])UYG\=]$F
MUCX97$T'F%].N([PQI&7+J,HW3H LA<GG 4_4 'R91110!8L+ZXTS4;:_LY/
M+NK659H7V@[74@J<'@X('6ON^PNTU#3K:]B&([B)95&]7P& (^9"5/7JI(/8
MD5\$5];_  ,U7^T_A?91D0!K&62U80KMZ'<-PVJ-V'&2-V>I;<6  /2****
M"OE#X]ZS>:A\3+G3IG_T738HXK>,$X&]%D9B"<;B6P2,9"KZ5]7U\(:[J?\
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M(53@@CB,$<@9?+*RD I_'3XF_>\(Z#??WDU66(?0"$/GZ[P!Z+G[ZU\_T44
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M57((( +*PW$X"C&2V "IPP^,*^T_B<2OPR\1$1R/_H3C"/(I^N8P3@=2"-I
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MO."Y4=NO4=:W*\(_:.\3R06>F>&+:?;]HS=W:#<"4!Q&"?NE2P<D<\HIXXR
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MFTS8BR6,3O-/&Y)!9%()9/NY^9B"Q.-HX\3K[_K@_''PF\.>.'DO)TDLM69
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M^SRN[XE2'RIWVZ?*=T4FU4^9!EQN&Y><8PWS%3CC</J>@ HHHH **** ./\
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MS/X#$GX5V8,<BXN)@"SR,&^<\J& "CMA"5R"<[BP'IE !1110 4444 %%%%
M!115>_OK?3-.N;^\D\NUM8FFF?:3M102QP.3@ ]* /F3]H77VU+QY%I"M)Y&
ME6ZJ49% \V0!V92.2"OE#GNIP.Y\CJYJVI3:SK-]JEPL:SWMQ)<2+&"%#.Q8
M@9).,GU-4Z "O2/@=X>M]?\ B5;/=-^[TV(WX3!^=T90G((QAG5N^=N",&O-
MZ^I_V?\ 0$TWX?\ ]K"?S)-6E:1D\I5\L1LT8&[&YNA/)P,\ '<6 /6****
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M\EGQ(^^1#N5>ZC9@GL67UKZ7KPC]FBTD33O$5Z3^[EE@B4;&ZH')^;&T_?'
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MY=U:RK-"^T':ZD%3@\'! ZT ?>]%9^AZS9^(=#LM7L'WVMW$LJ9()7/56P2
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M(YR+)%WI*K@ <!<JJC*@;2,9!!!+$%CUE<G\,26^&7ATF.1/]"08=Y&/US(
M<'J !M ("DJ%)ZR@ HHHH **** /@"BBB@#T#X)?\E>T+_MX_P#1$E?7]?('
MP2_Y*]H7_;Q_Z(DKZ_H **** "BBB@ HHHH **** "BBB@ HHHH **** "L?
MQ5XAM_"GA?4-<NEW1VD1<)DCS')PB9 .-S%1G'&<GBMBO$/VCO$7V;0],\/0
MRXDO)3<W 2;!$:<*K(.JLS9!/&8NY' !\WT444 %=1X<^(GBKPEITEAH>J?9
M+624S,GV>*3+D $Y=2>BC\JY>B@#T#_A=OQ#_P"AA_\ )*W_ /C=22?''X@N
MD*KK4<9C3:S+9PYD.XG<V4(S@@<8&%'&<D^=T4 >D?\ "]?'WD>7_:D&[RO+
M\S[)'NW;]V_[N-V/DZ;=O;=\U$WQU\?2_:-FJ01>;*)$V6D9\E?F^1<J<KR/
MO;F^4<]<^;T4 >B3_''X@S7$LJ:U' CN66*.SA*H"?NC<A.!TY)/J30/CC\0
M1;O$=:C+LZL)39P[E !RH^3&#D$Y!/RC!'.?.Z* "BBB@ KK/AMXE7PGX\TW
M4Y[N2VLPYBNV6-G!B88(90P)&<'O@@':Q 4\G10!]_T5Q_PN\1?\)/\ #K2+
MZ27S+J.+[-<EIO-?S(_E+.>NY@ ^#S\XZ]3V% !1110 4444 %%%% !1110
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M7PAH4?F^(=,C\OS-]W$NS9OW9<<;=C[OIL?/]UNA^[Z "BBB@ HHHH ****
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M8]>K$D]R37VOXZO/[/\  /B"Z";V33Y]H,'G L4(&Y,$%<D9R-H&2>,U\04
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M?><L5(YP5*D9^F #Z'\<>./#/A'2Y$UZ6.X,Z!/[.0+)+.CY4_NV(&S ;);
MX(ZD _&$\BS7$LJ0QP([EEBC+%4!/W1N).!TY)/J31//-=7$MQ<2R33RN7DD
MD8LSL3DDD\DD]Z]0^&7P=U+Q7<1:IK$4ECHL;QR!9HF#7JY#%4Y4A"I_U@/<
M8SS@ \O@GFM;B*XMY9(9XG#QR1L59&!R"".00>]?1GPL^-EOJ$4>A^*[B"SN
M(8E6WU"60A)@J@$2LY.)#@G<3ALD<'&X^(GP&M]0BBOO!L4%G<0Q".6Q=R$F
M"KA2K'.)#@ [CAL[B0<EOG.>":UN);>XBDAGB<I)'(I5D8'!!!Y!![4 ??=%
M?+GPP^,]]X:N+72/$,\EUH(00QR%=TEF 3@@@9=!G!4Y( &WIM/U'0 4444
M%%%% !1110!\T?M':-]D\6Z9JZ) D=_:&)M@P[R1-RS<<_*\8!R3\N. !7B]
M?4_[0>C?VA\.EU%$@\S3;N.5I''SB-_W953CNS1DC@';Z@5\L4 %7-)U*;1M
M9L=4MUC:>RN([B-9 2I9&# '!!QD>HJG10!]]P3PW5O%<6\L<T$J!XY(V#*Z
MD9!!'!!'>OASQ7K/_"0^+=6U</.\=W=R2Q>><NL98[%/)QA=HP#@8P.*^F]*
M\406/[/-OK321J+?1_LZ%'EP95'DH-RA'4EP 2N-I)PV &KY,H ***N:3ILV
MLZS8Z7;M&L][<1V\;2$A0SL%!. 3C)]#0!]9_!;1/[$^%^E[[?R;B^W7LOS[
MM^\_(W4@9C$? Q[C.:] JO86-OIFG6UA9Q^7:VL2PPIN)VHH 49/)P .M6*
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M'78N,X_UJ9QA]GTGX.TIM#\':5I4EM';RV=NL$JQA=KNO#2#'4.V7R<$[OF
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M\K9VMS]UCP>A /CBBBB@ K['^#[;OA1H!\V"7]TXW01[%&)'&"-J_,.C''+
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M#(X."#TK8J.""&UMXK>WBCA@B0)''&H544#   X  [5)0 4444 <?\4?#O\
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MQ!MBC7:1CRMS!B<GEL]%P 1D^J444 %<7X^^&>B^/[>-KPR6NH0(RP7L(&X
M@X5P?OH&.<<'K@C)SVE% 'D?PI^#R^$+C^VM;:.?6$=EMUC+!;< R(6!#8<.
MA4_,H*^@.:]<HHH **** "BBB@ HHHH Q_%>C?\ "0^$M6T@) \EW:211>>,
MHLA4[&/!QAMIR!D8R.:^&*^_Z^*/B-HW]@?$77M."01QK=M+%' ,(D<G[Q%
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M&7Z;MAQG'3>N<?=?&4^CZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MTSJ2#CAE0AA[@D'M7QY10!]AP_&?X?3N43Q%&"$9_GMID&%4L>60#.!P.I.
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M9]>&?M(>'YKG2])\06]M&R6CO;W4BH2X5\&,L0/N!@PY/!D&/O&@#YSHHHH
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MK'1-+M],TRVCMK.W39%$@X4?S))R23R223R:N4 %%%% !1110 4444 %%%%
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M>?\ P;T#4?#GP_CL=5L_LEW]KG9XSMW<-MR<*,YV\$E\KM(;!"KZ!0 4444
M%%%% !7A'[2/B&W&G:3X:5=UT\OV^0Y(\M 'C7M@[BS]^-G3D5[O7S!\3?!O
MCGQ7\1=4OHO#U\]J)5MK4^:'3RU\M0RDD!58R!\=!NDS]QR #Q^BNPC^%?CF
M39M\,WPW[<;E"_>\O&<GC_6KG/3#YQL?:/\ "OQRD2R'PS?;6B$P 4$[2KL
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M#^+?A02#@.W3.1ES_"7QY;"4OX:NSY;E&\MD?)$?F<;6.X;>,C(+?*/F^6K
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MVS_A#=#_ +1\_P"W?V?!]H^T9\SS/+7=OW<[LYSGG- &Q1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %?,'QY_Y#DG_ &%9_P#TBT^BB@#Q^BBB@#Z _9\_Y=?^
MXG_[CJ]_HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
B**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
